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Maintaining genomic integrity is critical to avoid sequence mutations and 
genetic disease. However the immune system requires genomic rearrangements 
in order to produce novel antibodies and elicit a full immunological response. The 
expression of DNA modifying enzymes is essential for antibody production but 
the off target effects are not well understood. The work presented here was 
performed to elucidate molecular mechanisms responsible for the regulation and 
targeting of DNA editing enzymes, as well as characterize repair of these lesions 
at off target loci. 
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CHAPTER I 
URACIL IN THE GENOME: MUTAGENIC THREAT AND IMMUNOLOGICAL  
NECESSITY 
 2 
Genomic DNA is constantly bombarded by a host of agents that modify 
the nucleic acid chemical structure, resulting in non-canonical base pairing and 
DNA damage. Threats to genomic DNA come from both external sources and 
also from naturally occurring cellular metabolic processes.  Some examples of 
exogenous sources of DNA damage are UV, ionizing radiation, and many DNA 
modifying chemicals. Endogenous sources of DNA modifications are products of 
cellular metabolism such as oxidative phosphorylation, lipid peroxidation, DNA 
replication errors, and enzymatic processing (McCullough et al., 1999). These 
DNA lesions are potentially mutagenic and must be repaired prior to replication in 
order to maintain the integrity of the genome and to avoid genetic diseases. 
One common DNA lesion that must be recognized and repaired in the 
genome is deoxyuracil. Spontaneous cytosine deamination (Figure 1A) to uracil 
is estimated to produce 100-500 uracil residues per cell, per day, with estimates 
orders of magnitude higher in transcriptionally active regions of the genome and 
in rapidly dividing cells (Lindahl, 1993). This is due to a high proportion of the 
genome adapting a single strand nature and are thus more susceptible to base 
modifications (Lindahl, 1993). Cytosine deamination leads to a U:G pairing and if 
left unrepaired result directly in a cytosine to thymine (CT) transition mutations 
(Olinski et al., 2010). Beyond spontaneous deamination, a cellular pathway for 
antibody diversification utilizes activation induced cytidine deaminase (AID) to 
enzymatically modify cytosine to uridine at the immunoglobulin (Ig) variable (V) 
locus within somatic B cells (Ganesh and Neuberger, 2011; Kato et al., 2012; 
Muramatsu et al., 2000; Wang, 2013). The manipulation of DNA repair in these B 
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cells leads to the uracil lesion not being faithfully repaired, resulting in novel 
antigen binding affinity (Figure 1B). This process is known as somatic 
hypermutation (SHM) (Chahwan et al., 2012). In humans AID is also required for 
the modification of the Ig heavy chain locus, which differentiates antibodies into 
their five different classes (IgM, IgD, IgG, IgA, and IgE). This process, known as 
class switch recombination (CSR), permits the cellular clearance of antibodies 
into restricted tissues and spaces within the body by performing programmed 
genomic translocations (Figure 1B) within the Ig locus (Chaudhuri et al., 2007). 
AID induced SHM and CSR are powerful adaptive immune tools however their 
processes must be tightly controlled because off target gene modifications, 
outside of the Ig locus, can lead to genomic instability and genetic disease 
(Nussenzweig and Nussenzweig, 2010).  
Targeting of AID to the Ig locus is not well understood, however there is 
evidence that monoubiquitination of multiple proteins is an important regulator of 
antibody diversification in model systems (Arakawa et al., 2006; Langerak et al., 
2007; Roa et al., 2008). Given that DNA repair enzymes are involved in SHM and 
CSR at the Ig loci, and genome wide maintenance, we speculate that histone 
modifications, in particular monoubiquitination, accompany hypermutation at the 
Ig locus. Chapter II: Histones H2A and H2B are Monoubiquitinated at AID-
Targeted Loci, provides evidence that, in humans (RAMOS) and mice, AID 
targets the Ig loci for SHM at least in part because of monoubiquitinated histones 
H2A and H2B. These results demonstrate for the first time a novel chromatin 
architecture being associated with SHM and genomic instability and show that 
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monoubiquitination of histones H2A and H2B act as molecular beacons for AID 
targeting. 
The essential role of AID on Ig gene diversification has led to the 
postulation that AID has high mutagenic potential at off target sequences. AID 
was once thought to be expressed only in B cells. However, it appears to be 
misexpressed in several non-lymphoid epithelial cancers and is a primary 
contributor to the observed genomic instability (Babbage et al., 2006; Endo et al., 
2011; Matsumoto et al., 2010; Shinmura et al., 2011). This high mutagenic threat 
argues for the existence of several molecular mechanisms to regulate AID 
expression outside of activated B cells. One such level of posttranslational AID 
control is accomplished through the expression of microRNA’s that target and 
prevent translation of the AID mRNA transcripts. In Chapter III: Repression of 
Human Activation iInduced Cytidine Deaminase by miR-93 and miR-155, the 3’ 
UTR of AID is characterized for the ability of miRNAs to regulate AID expression. 
Here we find that miR-155 and miR-93 regulate AID misexpression in the MCF-7 
breast cancer cell line and loss of either miRNA induces increased AID protein 
levels. The results here also provide evidence that the 3’ untranslated regions of 
mRNA contain sequence elements that make identifying miRNA target sites 
difficult and more care must be taken when publishing and annotating full length 
mRNA transcripts.  
Deaminated cytosines created enzymatically by the action of AID or by 
spontaneous deamination occur throughout the genome and lead to DNA 
transition (CT) mutations, unless the uracil intermediate is repaired (Maul and 
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Gearhart, 2010).  The uracil DNA glycosylase family of enzymes is responsible 
for recognizing genomic uracil lesions and initiating repair (Krokan et al., 2014). 
There are four uracil DNA glycosylase enzymes in mammalian cells: 1) uracil-
DNA glycosylase (UNG) is expressed in two isoforms with UNG1 in the 
mitochondria and UNG2 in the nuclear fraction, 2) single strand selective 
monofunctional uracil DNA glycosylase (SMUG1), 3) thymine DNA glycosylase 
(TDG), and 4) methyl-binding domain 4 protein (MBD4). It remains unclear how 
the uracil glycosylase family of enzymes share in the uracil processing 
responsibilities however UNG and SMUG1 are primarily responsible for the 
repair of deaminated cytosines and they are not redundant because both 
enzymes are required to limit the accumulation of DNA sequence mutations 
(Hagen et al., 2006).   
Much is understood about uracil DNA glycosylase processing on single 
strand and duplex DNA.  Even so, the human genome is composed of many 
structural DNA conformations that deviate from the traditional Watson-Crick B-
form double helix. Of particular interest are G quadruplex (G4) DNA structures as 
they are associated with programmed recombination of the Ig locus. In addition, 
some G4 capable sequences are associated with mutagenesis and genetic 
disease however the mechanism leading to this instability is not understood 
(Maizels, 2015). These observations led us to explore DNA repair abilities of 
uracil glycosylase enzymes near G4 capable DNA sequences. G4 DNA 
structures differ from Watson-Crick DNA in that G4 is a four stranded stable 
conformation forming from tandem guanine repeats under physiological salt and 
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pH conditions, resulting in a tetrad of four guanines participating in alternative 
DNA hydrogen bonds centered around a monovalent cation (Sen and Gilbert, 
1988, 1990). Sequences capable of adopting putative G4 DNA conformations are 
found throughout the human genome and many show up in untranslated regions 
of oncogenes where they appear to effect transcriptional efficiency (Eddy and 
Maizels, 2006; Huppert and Balasubramanian, 2005; Todd et al., 2005). In 
Chapter IV: G-Quadruplex DNA Structures Can Interfere With Uracil Glycosylase 
Activity In Vitro, the major uracil glycosylase enzymes from E. coli and humans 
are characterized for their ability to process uracil lesions near guanine repeats 
involved in G4 DNA structure formation. Here we show that uracils positioned 
directly 5’ or 3’ of guanine tetrads involved in G4 structural bonds have inhibited 
uracil glycosylase processing activity. These results provided a potential 
mechanistic explanation as to why guanine rich sequences are prone to 
instability and demonstrate that uracil DNA glycosylase enzymes are poor 
initiators of repair at these loci. 
In short, the work presented herein is focused on the targeting and 
regulation of the uracil inducing enzyme AID and the consequences of aberrant 
genomic uracil repair near guanine rich sequences. Chapter II identifies 
monoubiquitinated histones H2A and H2B as key markers for AID targeting and 
Ig gene diversification. Chapter III establishes both miR-93 and miR-155 as 
capable of regulating post-transcriptional AID expression and further 
characterizes the known AID 3’ untranslated region. Chapter IV explores the 
repair of deaminated cytosines near G4 capable DNA and demonstrates that G4 
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provides a unique molecular architecture and uracil located directly adjacent to 
guanines in G4 DNA are poorly processed by uracil glycosylase enzymes. 
Finally, Chapter V unifies the above findings and clarifies the future work that is 
needed to clarify the dynamic role that genomic uracil plays. All together this 
work is important because it uncovers fundamental mechanisms of mutagenesis, 
which are required to define the molecular sources of genomic instability. 
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FIGURE 
 
Figure 1. Cytosine Deamination and the Outcomes of Uracil DNA Repair.  (A) 
Chemical structure of cytosine (left) and the deamination product uracil (right). (B)  
Outcomes of uracil repair on the genome (left) and at the Ig locus (right). Spontaneous 
and AID induced deaminations convert cytosine to uracil. Genomic uracil can be fully 
repaired (bold) or the mutations cause CT transition mutations (grey). The Ig locus 
undergoes SHM and aberrant DNA repair of the deoxyuracils, which alters the 
nucleotide sequence for novel antigen binding (grey). During CSR the Ig locus performs 
DNA translocations between switch regions to generate mature antibodies of different 
classes (outlined). 
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CHAPTER II 
HISTONES H2A AND H2B ARE MONOUBIQUITINATED AT AID-TARGETED 
 LOCI 
 
 
 
 
 
 
 
 
 
 
 
Contributions: 
The contents of this chapter were previously published and cited below. My 
contribution involves experimentation excluding the microscopy with a minor 
contribution to manuscript preparation and editing. 
Borchert, G. M., N. W. Holton, K. A. Edwards, L. A. Vogel, and E. D. Larson, 
2010, Histone H2A and H2B are monoubiquitinated at AID-targeted loci: 
PLoS One, v. 5, p. e11641. 
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ABSTRACT 
Somatic hypermutation introduces base substitutions into the rearranged 
and expressed immunoglobulin (Ig) variable regions to promote immunity. This 
pathway requires and is initiated by the Activation Induced Deaminase (AID) 
protein, which deaminates cytidine to produce uracils and UG mismatches at the 
Ig genes. Subsequent processing of uracil by mismatch repair and base excision 
repair factors contributes to mutagenesis. While selective for certain genomic 
targets, the chromatin modifications which distinguish hypermutating from non-
hypermutating loci are not defined. 
Here, we show that AID-targeted loci in mammalian B cells contain 
ubiquitinated chromatin. Chromatin immunoprecipitation (ChIP) analysis of a 
constitutively hypermutating Burkitt's B cell line, Ramos, revealed the presence of 
monoubiquitinated forms of both histone H2A and H2B at two AID-associated 
loci, but not at control loci which are expressed but not hypermutated. Similar 
analysis using LPS activated primary murine splenocytes showed enrichment of 
the expressed VH and Sγ3 switch regions upon ChIP with antibody specific to 
AID and to monoubiquitinated H2A and H2B. In the mechanism of mammalian 
hypermutation, AID may interact with ubiquitinated chromatin because confocal 
immunofluorescence microscopy visualized AID colocalized with 
monoubiquitinated H2B within discrete nuclear foci. 
Our results indicate that monoubiquitinated histones accompany active 
somatic hypermutation, revealing part of the histone code marking AID-targeted 
loci. This expands the current view of the chromatin state during hypermutation 
 14 
by identifying a specific nucleosome architecture associated with somatic 
hypermutation. 
INTRODUCTION 
The immunoglobulin (Ig) genes in activated B cells are diversified by 
somatic hypermutation and class switch recombination to promote immunity. 
Somatic hypermutation introduces point mutations into the rearranged and 
expressed Ig variable regions while class switch recombination coordinates the 
exchange of one Ig constant region for a downstream region, deleting the 
intervening DNA. Both pathways require the Activation Induced 
cytidine Deaminase (AID) protein (Muramatsu et al., 2000; Revy et al., 2000). 
AID is active on transcribed DNA and functions to convert single-stranded 
cytidines into uracil and uracil-guanine mismatches (reviewed in (Chelico et al., 
2009; Conticello, 2008). Canonical mismatch repair and base excision repair are 
able correct genomic uracil (Larson et al., 2008; Pham et al., 2008; Schanz et al., 
2009), but in somatic hypermutation these normally faithful repair pathways 
become mutagenic (Rada et al., 2004). The diversion to mutagenesis is 
promoted by the synthesis activities of low-fidelity DNA polymerases, such as 
polymerase eta (reviewed by(Di Noia and Neuberger, 2007; Peled et al., 2008), 
and their participation in hypermutation may be regulated by PCNA 
monoubiquitination (reviewed by (Langerak et al., 2009) . While hypermutation is 
largely confined to the rearranged and expressed Ig genes, other B cell loci are 
prone to aberrant hypermutation, leading to lymphoma (Liu et al., 2008; Liu and 
Schatz, 2009). The molecular mechanisms responsible for targeting AID to 
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certain sites in the genome and the regulation of subsequent mutagenesis have 
not been established. 
Monoubiquitination pathways may be important for regulating Ig gene 
diversification. DT40 B cells disrupted for PCNA monoubiquitination by a K164R 
substitution showed decreased AID-initiated Ig gene diversification (Arakawa et 
al., 2006)]. Similarly, PCNA K164R knock-in mice had an altered spectrum of Ig 
gene mutagenesis, paralleling mismatch repair defective mice and suggesting 
that monoubiquitination of PCNA influences uracil repair outcomes in mammals 
(Langerak et al., 2007; Roa et al., 2008). PCNA modification may be facilitated in 
part by the RAD6 pathway because inactivation of a RAD6 associating E3 ligase, 
RAD18, in DT40 B cells resulted in reduced levels of PCNA monoubiquitination 
and decreases in hypermutation (Arakawa et al., 2006; Bachl et al., 2006), 
however residual PCNA monoubiquitination in rad18 mutant DT40 suggests the 
involvement of more than one E3 ligase (Simpson et al., 2006). Further evidence 
for protein ubiquitinations in Ig gene diversification pathways comes from recent 
studies on the RNF8 and RNF168 E3 ligases. Silencing of these two proteins 
decreased class switch recombination efficiency in a murine model B cell line 
(Ramachandran et al., 2010), and RNF168 was identified as the RIDDLE 
syndrome protein, a disease characterized by immunodeficiencies and DNA 
repair defects (Stewart et al., 2009). Recently, RNF8 knock-out mice were shown 
to have impaired class switch recombination and defects in DNA damage 
responses (Li et al., 2010; Santos et al., 2010) further connecting histone 
monoubiquitination with Ig gene diversification. Together, it is likely that multiple 
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proteins are monoubiquitinated to promote Ig gene diversification and 
hypermutation specific histone E3 ligases could serve as signals for locus-
specific mutagenesis. 
In light of the DNA repair machinery-driven nature of hypermutation at the 
Ig loci, characterized roles for chromatin monoubiquitination in facilitating normal 
DNA repair throughout the genome (reviewed by (Game and Chernikova, 2009), 
and the involvement of RNF8 in class switching (Li et al., 2010; Ramachandran 
et al., 2010; Santos et al., 2010), we speculated that histone monoubiquitination 
could accompany hypermutation. We therefore assayed the nucleosomes at AID-
targeted and actively hypermutating loci for ubiquitin modification. Here, we show 
by Chromatin Immunoprecipitations (ChIPs) that both histone H2A and H2B are 
monoubiquitinated at two different AID-targeted loci in the constitutively 
hypermutating B cell line Ramos. ChIP analysis of primary LPS activated murine 
splenocytes showed similar levels of enrichments for hypermutating template 
upon immunoprecipitation with antibody specific to AID, pol II, and 
monoubiquitinated forms of H2A and H2B. Furthermore, we find by 
immunofluorescence microscopy that AID colocalizes with monoubiquitinated 
H2B in discrete nuclear foci, suggesting that both are concomitant with 
hypermutation. Our results identify a considerable and previously 
uncharacterized chromatin modification associated with AID-induced somatic 
hypermutation. 
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RESULTS 
AID and Hypermutation Target Two Discrete Loci in Ramos 
Ramos is a human Burkitt's lymphoma cell line with both functional and 
non-functionally rearranged Ig heavy chain (IgH) loci. One IgH allele contains a 
productive VDJ rearrangement (re-VH), which is a gene that is expressed and 
constitutively hypermutated (Sale and Neuberger, 1998). The other IgH allele has 
participated in a reciprocal translocation between the ends of chromosomes 8 
and 14, replacing the antibody variable region on chromosome 14 with an 
intact c-MYC allele from chromosome 8 (MYC14), and this locus is also 
hypermutated (Bemark and Neuberger, 2000). The partially rearranged V region 
on chromosome 8 and the mu constant region downstream of re-VH are not 
diversified by hypermutation. Using EST data from the NCBI database, and 
previously reported c-MYC sequences(Bemark and Neuberger, 2000), we 
constructed a map of the rearranged and expressed heavy chain loci in Ramos 
(Figure 2). The documented constitutive hypermutation of Ramos re-
VH and MYC14 predict that AID selectively targets these two distinct loci for 
deamination. 
We first established active somatic hypermutation of the re-
VH and MYC14 in our Ramos subclone using standard surface IgM loss assays 
and direct sequencing ofMYC14. Constitutive sequence diversification of the 
expressed IgM locus results in mutations that inactivate surface display, 
providing a marker for hypermutation rate in Ramos. Starting from a single 
Ramos sIgM positive isolate, 90 days of continuous culture resulted in 6.83% 
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sIgM loss, as measured by FACS with FITC-conjugated anti-IgM antibody 
(Figure 3). This compares well with the sIgM loss rate reported for Ramos, 
showing 4% sIgM loss for after 4 weeks of in vitro culture (Yabuki et al., 2005), 
and ∼17% loss after 6 months (Sale and Neuberger, 1998). We conclude that 
the re-VH is actively hypermutated. To ensure ongoing hypermutation of the other 
IgH locus, individual expressed MYC14 clones of from our Ramos population 
were sequenced, and 20% of our sequence reads contained one or more novel 
mutations (6/30, mean length = 748 nt) (Figure 3B). Only the translocated c-
MYC is expressed in Ramos, and MYC14 contains a single nucleotide 
polymorphism A523T(Bemark and Neuberger, 2000), distinguishing it from the 
non-translocated allele. This base substitution was present in all sequence reads 
we obtained. The MYC14 point mutations we identified are novel, and do not 
correspond to previously identified c-MYChypermutations (Bemark and 
Neuberger, 2000). We conclude that both the re-VH and MYC14 in our Ramos 
subclone are expressed and subject to hypermutation, as expected. 
AID activity is required for initiating somatic hypermutation, predicting that 
the protein should be in physical contact with both the Ramos re-VH and c-
MYC genes. To test this, we used chromatin immunoprecipitations (ChIPs) to 
test for AID association with hypermutating loci in Ramos. ChIPs rely on specific 
antibodies to precipitate crosslinked protein-DNA complexes, followed by 
quantitative PCR (qPCR) analysis of the enriched genomic templates. Primer 
sets were designed to amplify templates immunoprecipitated from Ramos cells 
corresponding to the re-VH locus (VH 1–3), thec-MYC gene (exons 1–3), and 
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several non-hypermutating control loci (Figure 2). In chromatin prepared from 
Ramos cells, the normalized enrichment of the re-VH using anti-AID antibody was 
13.8-fold (Figure 4A). Likewise, AID ChIP enriched for exons 1–3 of c-MYC (11.9 
fold, 14.0 fold and 10.8-fold, respectively) (Figure 4A). AID ChIP did not enrich 
for any of the other loci tested, including a distal downstream (50 kb) region 
ofMYC14 (MYC4), the Cmµ constant region (VH-Cµ), the non-productively 
rearranged heavy chain V region on chromosome 8 (V8), and the β actin gene 
(Figure 4A). To further test hypermutation specificity ChIPs with PCNA and pol 
eta antibodies enriched for the re-VH (Figure 7), and AID antibody failed to enrich 
for the c-MYC locus in AID negative HEK293 and A549 cells (Figure 8), and 
westerns with this same antibody did not detect AID in HEK293 extracts, but 
identified a single 24 kDa band in Ramos, as expected (Figure 9). In addition, IPs 
using this AID antibody and Ramos extract precipitated native AID, as detected 
by western with an independent AID antibody (Figure 10). 
Primers designed to amplify MYC14 could potentially amplify the other c-
MYC allele if precipitated during ChIPs; however, only the translocated c-
MYC contains the single nucleotide polymorphism A523T(Bemark and 
Neuberger, 2000). Further, ChIP results are suggestive of AID association 
with MYC14 because AID tracks with pol II to deaminate transcribed DNA 
(reviewed by (Larson and Maizels, 2004) and the non-translocated allele of c-
MYC is not expressed ((Bemark and Neuberger, 2000) yet pol II ChIPs enriched 
for exons 1–3 c-MYC. Most importantly, 100% (8/8) of different sequence reads 
from PCR product amplified from anti-AID ChIPed template corresponded to the 
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translocated MYC14 allele (not shown). Together, our results indicate that AID is 
physically associated with the Ramos re-VH and with exons 1–3 ofMYC14, 
supporting the model that both loci are subject to AID-initiated somatic 
hypermutation. 
Chromatin at the Re-VH and c-MYC Gene in Ramos B Cells is 
Monoubiquitinated 
Having confirmed AID associations at both re-VH and c-MYC in our Ramos 
subculture, we next examined the chromatin state at these loci to identify histone 
markers of hypermutation. Based on roles for histone ubiquitination in normal 
DNA repair (Game and Chernikova, 2009) and apparent involvement of 
RNF8/168 ubiquitin E3 ligases in class switch recombination (Li et al., 2010; 
Ramachandran et al., 2010; Santos et al., 2010; Stewart et al., 2009), we 
focused our analysis on ubiquitin-modified chromatin. We used ChIPs and 
antibodies specific to monoubiquitinated histones to ask if the re-
VH and MYC14loci are modified by ubiquitination. Analysis of qPCR following 
mUb-H2A ChIP of Ramos chromatin showed a 48.3 fold normalized enrichment 
of the re-VH. Exons 1–3 of c-MYC were also enriched, showing 18.4 fold, 23.0 
fold and 16.6 fold enrichments respectively (Figure 4B). Similar to the mUb-H2A 
ChIP, qPCR analysis following mUb-H2B ChIP of Ramos chromatin showed 
37.6-fold normalized enrichment of the re-VHand exons 1, 2, and 3 of c-
MYC showed 29.3 fold, 32.3-fold and 12.9-fold enrichments, respectively (Figure 
4C). In contrast, neither the VH-Cµ, V8, β-actin gene, nor MYC4 were enriched by 
mUb-H2A or mUb-H2B ChIP (Figure 4B, C). Also, mUb-H2A and mUb-H2B 
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ChIPs with AID negative HEK293 and A549 cells did not enrich for the c-MYCloci 
(Figure 8). We conclude that the re-VH and c-MYC loci in Ramos are occupied by 
nucleosomes that contain monoubiquitinated forms of H2A and H2B. 
Previous studies connect histone monoubiquitination with transcriptional 
silencing and/or polymerase elongation (reviewed by (Weake and Workman, 
2008) so we next asked if histone ubiquitination is a broad consequence of high 
RNA polymerase II (pol II) driven expression of the heavy chain loci in Ramos, or 
associated with mutagenesis. ChIPs using RNA pol II antibody and Ramos 
chromatin showed comparable enrichment via normalized qPCR for the re-VH, 
exons 1–3 of c-MYC, β-actin, and VH-Cµ. We did not observe enrichment of the 
unrearranged VH locus (V8) or the region downstream ofMYC14, MYC4, which 
was anticipated because these regions are not expressed. In contrast, β-actin, 
and VH-Cµ were all enriched by pol II ChIPs (Figure 4D), but not after ChIP using 
monoubiquitinated histone antibody (Figure 4B, C). These results mirror our AID 
analyses, and suggest that pol II-dependent gene expression alone is insufficient 
for establishing sustained chromatin monoubiquitination in Ramos. 
If monoubiquitinated chromatin is associated with Ig gene mutagenesis, 
we also anticipate other hypermutation factors will be associated with these 
same loci. AID-induced uracil is processed by mismatch repair factors at the Ig 
loci, and substitutions are introduced opposite A and T bases through PCNA-
dependent recruitment of pol eta synthesis in place of pol delta (reviewed by 
(Langerak et al., 2009). ChIP analysis suggests that the re-VH, but not the 
unrearranged allele (V8), is in physical contact with PCNA and pol eta (Figure 7), 
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supporting the model that the monoubiquitinated loci we identify here also harbor 
proteins known to support mutagenesis in response to uracil in DNA. The qPCR 
enrichments obtained for Ramos ChIPs were independently verified by 
qualitative, traditional PCR amplification and ethidium bromide visualization 
(Figure 4E) and westerns verified specificity for AID and monoubiquitinated 
histone antibodies (Figure 4F). 
The Chromatin of Ig Genes in Activated Primary Murine B Cells is 
Ubiquitinated 
It is possible that chromatin monoubiquitination is a unique feature of 
Ramos hypermutation. To address this, we tested histone monoubiquitination of 
an AID-targeted locus in LPS activated murine B cells. Typically, hypermutation 
is difficult to quantify by PCR in primary cells because of the sequence variability 
inherent to the rearranged Ig genes. To overcome this technical limitation, we 
used a quasi-monoclonal mouse, which was engineered to contain a functional 
IgH chain allele generated by targeted replacement of heavy chain locus variable 
region with a defined VDJ rearrangement (17.2.25)(Cascalho et al., 1996) 
(Figure 5A). The 17.2.25 VDJ region in these mice is subject to diversification by 
somatic hypermutation(Cascalho et al., 1998). 
Primary splenocytes were isolated from six healthy quasi-monoclonal mice 
and cultured with lipopolysaccharide (LPS) to activate primary B cells. ELISAs for 
secreted IgG confirmed activation of Ig gene diversification (data not shown). In 
chromatin prepared from these activated splenocytes, normalized enrichment of 
17.2.25 after ChIP with mUb-H2A and mUb-H2B antibody showed robust 
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enrichment, 16.2-fold and 21.8-fold for each antibody, respectively (Figure 5). 
Similarly, pulldowns using these same antibodies were also enriched for the Sγ3 
switch region (Figure 5). AID appears to target the 17.2.25 and Sγ3 loci after 
activation because anti-AID ChIPs resulted in 10.4 and 7.1 fold enrichments of 
these regions respectively (Figure 5B, C) The murine triose phosphate 
isomerase gene (TPI) and unexpressed neural specific gene (STEP) were used 
as controls, and only the TPI locus showed modest enrichment (6.9-fold) after pol 
II ChIP, and neither locus was precipitated upon IP with anti-AID, anti-mUb-H2A, 
or anti-mUb-H2B. Due to the limited antibody repertoire encoded by the quasi-
monoclonal mice, selective pressure for Ig gene diversity is high, causing both 
hypermutation and frequent V gene replacements(Cascalho et al., 1998). 
Because it is unlikely that 17.2.25 gene rearrangements would be amplified by 
our primer sets, enrichments we obtained for the 17.2.25 locus after AID ChIP 
(Figure 5B) are likely to be an under-representation of the actual level of AID 
association. Regardless, we conclude that the 17.2.25 and Sγ3 loci from primary 
LPS activated quasi-monoclonal murine splenocytes are expressed by RNA pol 
II, targeted by AID, and occupied by monoubiquitinated histone H2A and histone 
H2B. 
AID and MUb-H2B Colocalize in Discrete Nuclear Foci 
ChIPs examine total cellular populations, and hypermutation events may 
occur transiently and at unsynchronized time points. Therefore, we used 
immunofluorescence confocal microscopy to ask if AID and ubiquitinated 
chromatin co-occupy the DNA. Both mUb-H2B and AID antibody produced clear 
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robust signals in Ramos cell preparations. Figure 6 shows a representative 
image of AID and mUb-H2B foci in Ramos, and overlay of these images showed 
clear colocalization of AID and mUb-H2B signal in discrete nuclear foci. We also 
found multiple examples where more than one AID and monoubiquitinated H2B 
are colocalized within a single cell nucleus (Figure 11), supporting the notion that 
at least two and possibly more loci are diversified by somatic hypermutation in 
Ramos cells. We observe multiple AID foci in individual Ramos cells, highly 
consistent with the behavior of endogenous AID (Cattoretti et al., 2006; 
Patenaude et al., 2009; Yang et al., 2005). It is possible that non-Ig genes are 
bound and deaminated by AID in Ramos. Antibodies to mUb-H2A and mUb-H2B 
antibody are specific for the monoubiquitinated forms of histones, and our 
westerns probing Ramos whole cell extract clearly show single bands at ∼25–30 
kDa (Figure 4F) corresponding to the size of a single histone ubiquitination (∼28 
kDa). Even though mUb-H2A, and mUb-H2B antibodies were competent for 
western analyses (Figure 4F) and ChIPs (Figure 4 and 5), we were unable to 
clearly detect mUb-H2A by immunofluorescence microscopy. Nevertheless, our 
imaging results suggest that AID is spatially and temporally associated with 
ubiquitinated nucleosomes. 
DISCUSSION 
Our results show that genomic loci that are targeted for somatic 
hypermutation are also occupied by monoubiquitinated chromatin. Histone H2A 
and H2B monoubiquitination was coincident with transcription, but not due to pol 
II catalyzed gene expression alone because anti-mUb-H2A and mUb-H2B ChIPs 
 25 
failed to enrich for the highly expressed Ramos β actin locus or the TPI gene in 
primary mouse splenocytes, even though pol II ChIP enriched for these regions 
at levels comparable to the re-VH, c-MYC Exons 1–3, and 17.2.25 (Figure 4 and 
5). Furthermore, the only genomic regions enriched by mUb-H2A and mUb-H2B 
ChIP were those that were also enriched upon anti-AID ChIP (Figure 4A); and 
these same loci also showed significant enrichments after ChIP with antibodies 
to the DNA repair factors PCNA and pol eta (Figure 7), which are two proteins 
involved in somatic hypermutation opposite A and T bases (recently reviewed 
by(Langerak et al., 2009). Histone monoubiquitination may occur in response to 
AID activity, but could also be a signal for AID recruitment because AID 
colocalized with mUb-H2B as visualized by immunofluorescence microscopy 
(Figure 6). Either way, our results identify the presence of both histone H2A and 
H2B tail monoubiquitinations at genes that are targeted selectively for 
mutagenesis, identifying this specific set of chromatin modifications with genomic 
loci that are deaminated by AID and mutated by responding DNA repair 
pathways. As such, co-occupancy of monoubiquitinated H2A and H2B within 
nucleosomes at the Ig genes may in part characterize the chromatin architecture 
associated with somatic hypermutation. 
Histone termini extend away from the core histone octamer as tails that 
serve as acceptors for a wide range of post-transcriptional modifications. The 
combination of these modifications or “histone code” regulates a wide range of 
functions, although the specific DNA level activities triggered by various 
combinatorial signals have not been completely defined. In hypermutation, some 
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small molecule histone modifications have been described. Acetylation of histone 
H3 and H4 at the IgH variable region, but not the constant region, results from 
activation of hypermutation in BL2 cells, suggesting a role in targeting somatic 
hypermutation machinery (Woo et al., 2003). However, in primary mouse B cells 
changes in histone acetylation at hypermutating loci did not follow with B cell 
activation (Odegard et al., 2005). Nevertheless, H4 acetylation may be important 
for some types of AID-initiated diversification because disruption of the E2A 
transcription factor in DT40 leads to decreases in H4 acetylation and gene 
conversion(Kitao et al., 2008). One unique signal for V region hypermutation may 
be phosphorylation of histone H2A at serine 14 (Odegard et al., 2005), and it is 
possible that this signal may operate in concert or in response to histone 
monoubiquitination to promote hypermutation. More than likely, locus-specific 
mutagenesis in B cells depends upon the combinatorial signal generated through 
multiple histone tail modifications, and further studies are required to decipher 
the specific histone code assigned to somatic hypermutation. 
H2A and H2B monoubiquitination may have active roles in the 
hypermutation pathway, and immunofluorescence results confirm proximity of 
AID and monoubiquitinated H2B (Figure 6 and 11). Chromatin modification may 
occur as a consequence of AID activity to promote mutagenesis at some loci, or 
histone monoubiquitinations could help recruit AID. These models are not 
necessarily mutually exclusive. If chromatin ubiquitination is important for 
regulating the balance between mutagenic and faithful DNA repair in Ig gene 
hypermutation, one might predict that AID could deaminate multiple genes but 
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the resulting uracils are faithfully repaired at the non-Ig loci. Indeed, we and 
others have observed multiple AID foci by immunofluorescence microscopy 
(Figure 6 and 11) (Cattoretti et al., 2006; Patenaude et al., 2009; Yang et al., 
2005), and genome sequencing of germinal center B cells reveals that AID acts 
widely at transcribed genes, but genomic instability is largely suppressed by 
faithful DNA repair(Liu et al., 2008). There are likely to be signals specific to only 
some genes (like the Ig loci) that regulate the switch from faithful to mutagenic 
uracil repair, and because mUb-H2B appears to occupy only a small subset of 
the AID-targeted loci (Figure 6 and 11), chromatin ubiquitination is not an 
automatic result of AID binding but rather a locus-specific event. It is conceivable 
that the conspicuous presence of ubiquitinated H2A and H2B at the Ig genes 
represents a signal that marks these loci for mutagenesis. 
Consistent with a model whereby histone monoubiquitination facilitates the 
repair responses to DNA deamination, recent studies have identified histone-
specific E3 ubiquitin ligases in class switch recombination. Starting with histone 
H2A modification, ubiquitination cascades appear critical for establishing 
assembly of recombination factors at sites of AID activity. The loss of the 
RNF168 H2A E3 ligase disrupts histone ubiquitination and causes DNA repair 
defects and immunodeficiencies associated with RIDDLE syndrome (Stewart et 
al., 2009); and RNF8 works in concert with RNF168 to initiate and expand 
histone ubiquitinations at the Ig loci that resulting in 53BP1 activity and proper 
class switching(Li et al., 2010; Santos et al., 2010; Stewart et al., 2009). In 
normal break repair, chromatin ubiquitinations promote assembly of DNA 
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damage response factors at sites of ionizing radiation damage (Huen and Chen, 
2010). Furthermore, the replication cofactor PCNA, which we found physically 
associated with the re-VH (Figure 7) and may be a lynchpin for regulating A/T 
biased hypermutation(Langerak et al., 2009), colocalizes with monoubiquitinated 
H2A (Vassilev et al., 1995). Upon AID activity, chromatin ubiquitination may 
signal assembly of hypermutation factors and/or ubiquitination cascades that 
regulate the shift between faithful uracil repair and mutagenesis. However, 
further studies are required in order to identify the ubiquitin E3 ligases functioning 
in normal and aberrant somatic hypermutation. 
Histone monoubiquitination is a substantial chromatin modification, and 
suggests the DNA at AID-targeted loci is accessible for metabolism. Unlike small 
molecule modifiers like phosphates or acetyl groups, ubiquitin is an 11 kDa 
protein. The addition of a single ubiquitin on both H2A and H2B would increase 
nucleosome mass by nearly 40%, which may greatly influence the association 
between DNA and the core histones or create an assembly site for repair factors. 
The significant enrichments we obtained by ChIP of the re-VH and MYC14 with 
mUb-H2A and H2B antibodies (Figure 4B, C) suggest the presence of a highly 
ubiquitinated locus, with multiple antibody binding targets at the site of 
hypermutation, but apparently not extending into the IgH constant region 
(VH1 amplicon Figure 4B, C) . Thus, histone monoubiquitination is localized to the 
DNA regions that are also bound by AID. It follows that VH1, and likely the 
proximal S region, were not enriched by AID ChIP (Figure 4A, C), which is 
expected because Ramos does not class switch. Because AID is active on 
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single-stranded DNA and associated with the re-VH (Figure 4A), it is conceivable 
that histone monoubiquitination creates a chromatin architecture that is 
permissible to AID attack or downstream uracil repair. Indeed, nucleosomal DNA 
is protected from AID in the absence of transcription (Shen et al., 2009), 
suggesting that deamination by AID may require histone remodeling and 
chromatin-level signaling. Importantly, our results identify a new chromatin 
modification associated with hypermutation and future studies will be required to 
next define functional roles in mechanisms of somatic hypermutation. 
MATERIALS AND METHODS 
Cells and Cell Lines 
Ramos cells were purchased from the ATCC and were cultured in 
suspension at 37°C in RPMI (10% (v/v) FBS, 1% (v/v) PS, 2 mM L-glutamine) 
(Life Technologies, Grand Island, NY) in 75 cm2 flasks. Following limiting dilution 
cloning, a sIgM positive isolate was expanded for 90 days, and then analyzed for 
sIgM loss by flow cytometry. Ramos cells were collected by centrifugation at 
300×g for 10 minutes, washed once with ice-cold PBS, and then resuspended in 
100 µL PBS and incubated with 10 µL of anti-human-IgM antibody (Sigma, St 
Louis, MO) for 10 minutes at 4°C. Cells were again collected, washed twice with 
PBS, resuspended in 100 µL PBS and incubated with 3 µL of FITC-conjugated 
anti-goat Ig secondary for 10 minutes at 4°C in the dark. Cells were washed 
twice with PBS then resuspended in 400 µL PBS. Samples included 10% normal 
rat serum to prevent non-specific binding. Cells were analyzed immediately on a 
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Becton Dickinson FACS Calibur flow cytometer using CellQuest Pro software 
(San Jose, CA) with 1×104 events collected. 
Chromatin Immunoprecipitations 
Approximately 1×107 cells were transferred to a 15-ml Falcon tubes and 
incubated for 10 minutes with 1% (v/v) formaldehyde. Chromatin was sheared by 
sonication to generate fragments averaging 500 bps, as judged by agarose gel 
electrophoresis. ChIPs were performed on prepared chromatin using EZ-ChIP kit 
reagent buffers (Millipore, Temecula, CA, 17–371) and standard manufacturer 
protocol. ChIP primary antibodies were as follows: normal mouse IgG negative 
control (Santa Cruz Biotechnology, Santa Cruz, CA, sc-2025), anti–RNA 
polymerase II (Millipore, 05-623B), anti-mUb-H2A (Millipore, 05-678)(Pinato et 
al., 2009), anti-ub-H2B (Millipore, 05-1312) (van der Knaap et al., 2010), anti-AID 
(Santa Cruz, sc-25620), and polyspecific IgG (Santa Cruz, sc-2025). Crosslinks 
were reversed by incubating chromatin at 65°C overnight, and enriched DNA 
template analyzed by traditional PCR and quantified by real-time PCR (described 
in PCR analyses). 
Western Blotting 
Ramos cells at ∼1×106 cells/ml, were collected by centrifugation, existing 
media removed, and cells resuspended in SDS lysis buffer containing protease 
inhibitors, and transferred to 1.5 ml Eppendorf tubes. Proteins were 
electrophoresed through a 4–12% SDS–polyacrylamide gradient gel (Invitrogen) 
and transferred to immobilon-P PVDF membranes (Millipore). Membranes were 
blocked for 1 hour in 5% (w/v) nonfat milk in phosphate-buffered saline 
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containing 0.05% Tween 20, washed, and incubated with primary antibody 
overnight at 4°C using the following dilution: anti-mUb-H2A (Millipore, 05-678) –
1∶500, anti-ub-H2B (Millipore, 05-1312) – 1∶500, and anti-AID (Santa Cruz, sc-
25620) - 1∶1000. Membranes were washed and incubated with secondary Abs: 
HRP conjugated goat anti-mouse and goat anti-rabbit (Invitrogen) at 1∶10000 
dilution. Immunoreactive bands were visualized with ECL Plus (Amersham, 
Piscataway, NJ) and signals were detected by using the Storm 840 
PhosphorImager and IMAGEQUANT software (GE Healthcare Life Sciences). 
PCR Analyses 
Oligonucleotide sequences from all analyses are detailed in Table II-S1. 
Sequencing of Ramos c-MYC was performed as described previously (Bemark 
and Neuberger, 2000). Briefly, total Ramos RNA was converted to cDNA via RT-
PCRs using random 20-mers and Protoscript Reverse Transcriptase (New 
England BioLabs (NEB), Ipswich, MA). Unless otherwise indicated, PCR 
amplifications were performed in 40 µl reactions at standard concentrations (1.5 
mM MgCl2, 0.2 mM dNTP, 1× NEB PCR buffer, 0.5 U Taq (NEB), 0.5 uM each 
primer) and then cloned into Topo TA PCR 2.1 (Invitrogen, Carlsbad, CA, 
K450001) for sequencing. MYC14 was distinguished from c-MYC on chromosome 
8 by the presence of an A at position 523 to T polymorphism found withinMYC14  
(Bemark and Neuberger, 2000). Traditional ChIP amplifications from recovered 
DNA was quantified by standard SybrGreen quantification (Invitrogen), then 
diluted to 0.1 ng/µl. PCR reactions were performed for 25, 30 or 35 cycles (as 
described above). Starting material was standardized across all reactions (0.1 ng 
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eluted DNA), excluding inputs, which were titrated from 0.5 ng to 10 ng per 
reaction. Following amplification, products were resolved by 1.5% agarose gel 
electrophoresis. The identities of all amplicons were verified by Topo TA PCR 2.1 
cloning and sequencing. Quantitative PCR (qPCR) used a series of primer pairs 
generated for each genomic locus using the Integrated DNA Technology design 
tool, PrimerQuest (https://www.idtdna.com). Individual amplicons were each 
evaluated by standard PCR ethidium bromide visualization, dissociation curve 
determination, and direct sequencing. A final validated primer pair was then 
selected for each locus (Table II-S1). Recovered DNA was diluted 1∶100 with 
ddH20 and 20 µl reactions prepared using DyNAmo SYBR Green qPCR 2× 
master mix (NEB, F400L) and ROX Reference Dye for Quantitative PCR (Sigma, 
R4526) were assembled in triplicate. Reactions were performed using an Applied 
Biosystems 7300 Real-Time PCR thermocycler (ABI, Foster City, CA) and DNA 
enrichments calculated by standard delta-delta Ct. 
Quasi-Monoclonal Mouse Primary B Cells 
Spleens from six healthy quasi-monoclonal mice (created by(Cascalho et 
al., 1996) were removed aseptically, placed in PBS and gently ground between 
frosted slides to produce a single-cell suspension. The suspension was 
centrifuged at 300×g for 5 minutes, the pellet was resuspended in ammonium-
tris-chloride buffer to hypotonically lyse erythrocytes, and the remaining cells 
were washed with PBS by centrifugation at 300×g for 5 minutes. Splenocytes 
were cultured at 37°C/5% CO2/95% humidity in 75 cm2 flasks in RPMI 1640 (Life 
Technologies) supplemented with 100 U/ml of penicillin, 100 mg/ml of 
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streptomycin and 10% FBS. Cultures were allowed to recover for 1 hour then 
supplemented with 25 µg/ml LPS (Sigma, L2143) and incubated for 72 hours to 
induce proliferation. Active Ig gene diversification was monitored by ELISA of the 
RPMI media for the presence of IgG, a result of LPS induced class switch 
recombination, as described (Blaeser et al., 2008; Cascalho et al., 1999) and by 
ChIPs to show AID association with the 17.2.25 locus (Figure 5B). Cells were 
collected after 72 hours and immediately crosslinked with formaldehyde for ChIP 
analysis as described. 
Confocal Immunofluorescence Microscopy 
Hypermutating Ramos cells were cultured in suspension at 37°C in RPMI 
(10% (v/v) FBS, 1% (v/v) PS, 2 mM L-glutamine) in 75 cm2flasks. 
At ∼1×106 cells/ml, 750 µL of Ramos suspensions were transferred into 
individual poly-lysine/ConA-coated chambered slide wells and incubated at 37°C 
for 1 hour to allow adhesion. Cells were rinsed twice with PBS then fixed with 2% 
paraformaldehyde for 20 minutes. Cells were again rinsed twice with PBS then 
blocked with for 30 minutes (PBS, 1% Goat serum, 0.2% TritonX-100). Cells 
were next incubated with primary antibodies diluted 1∶1000 in PBTG (PBS, 1% 
Goat serum, 0.2% TritonX-100) for 2 hours at room temperature. Cells were 
rinsed 3 times with PBTG then incubated in the dark for 2 hours at room 
temperature with secondary antibodies diluted 1∶1000 in PBTG. Cells were again 
rinsed 3 times with PBTG then mounted with vectashield (Vector Laboratories, 
Burlingame, CA, H1000). Confocal images were obtained using a Leica TCS 
SP2 Confocal Microscope and contrast processed with Adobe Photoshop 7.0 
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software. Primary antibodies included: anti-mUb-H2B (Millipore, no. 05-1312) 
and anti-AID (Santa Cruz, sc-25620). Anti-mUb-H2A (Millipore, 05-678) was also 
examined but produced no discernable immunofluorescence microscopy signal. 
Secondary Abs were goat anti-mouse conjugated to Alexa 555 and goat anti-
rabbit conjugated to Alexa 488 (1∶1000) (Invitrogen). DAPI (1∶1000) Alexa 633-
wheat germ agglutinin (1∶1000) was used to stain nuclear envelopes (Invitrogen).
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FIGURES 
 
Figure 2. Diagram of the IgH Loci in Ramos Burkitt's Lymphoma. A reciprocal 
translocation exchanging the ends of chromosomes 8 and 14 in Ramos resulted in the 
formation of MYC14 and V8. The chromosome 14 break point occurred within the heavy 
chain (IgH) switch region (indicated by jagged edges) just 5′ of the µ constant exon 
(IgHM) while the chromosome 8 breakpoint occurred in a c-MYC allele promoter. (R), 
silent, non-coding RNA; ×1, ×2, ×3, c-MYC exons. Arrows indicate transcriptional 
direction. Double bar denotes amplicon location. Primers were designed to amplify the 
IgH constant region mu (VH1), the functional heavy chain VH4-34/D/J6 rearrangement 
(VH2), and an upstream non-rearranged V-region sequence (VH3). Chromosome 8 
primer sets amplify three c-MYC exons (MYC1–3), and a sequence 50 kb 5′ of MYC3 
(MYC4). One primer set was designed for the non-expressed unrearranged VH 4–34 on 
chromosome 8 (V8). 
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Figure 3. Ramos Burkitt's Lymphoma Cells Constitutively Hypermutate at Distinct 
Genomic Loci. A. Flow cytometry measure of loss of surface IgM (sIgM) display over 
time for cultured Ramos cells. sIgM was detected using FITC conjugated antibody 
specific for human IgM (FL1-H). Ramos cells were continuously cultured for 90 days 
after which 10,000 cells were analyzed. B. Sequence analysis of the translocated and 
expressed MYC14. Each pie wedge represents a unique sequencing read with the 
number of mutations identified in individual reads indicated. The total number of 
mutations identified in 10 unique sequence reads corresponding to individual exons is 
shown in the central circles. 
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Figure 4. ChIPs Identify MUb-H2A and MUb-H2B at Ramos Hypermutating Loci. A. 
Normalized template enrichment upon anti-AID ChIP. Template obtained from AID-IP 
was amplified and analyzed by qPCR using primer sets diagramed in Figure 1, above. 
Results were normalized to non-specific IgG IP and relative to input. Each bar indicates 
the mean of the values obtained from six amplifications (two separate experiments 
analyzed in triplicate) with standard deviation. B. Normalized template enrichment upon 
mUb-H2A ChIP. C. Normalized template enrichment upon mUb-H2B ChIP. D. 
Normalized template enrichment upon pol II ChIP. Enrichments were analyzed by qPCR 
as in Figure 3A. E. Ethidium bromide stained gel of traditional PCR amplifications from 
ChIP template. F. Antibodies used to ChIP mub-H2A and mub-H2B and AID are specific 
for monoubiquitinated H2A, H2B and AID protein. Western blot analysis of endogenous 
AID (24 kDa), mUb-H2A (27 kDa) and mUb-H2B (27 kDa) in Ramos cell lysates. Visible 
on the AID blot, the white negative stained bands of the protein marker correspond to 
55, 40, 36, 25, 15 and 10 kilodaltons (top to bottom). 
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Figure 5. MUb-H2A and MUb-H2B Associate with Hypermutation in Activated 
Mouse Primary B Cells. A. Cartoon depicting the engineered rearranged heavy chain 
allele sequences in quasi-monoclonal mouse . The rearranged allele (17.2.25) is 
compared to a normal heavy chain arrangement (wt). The 17.2.25, allele formed by the 
targeted replacement of the joining cluster with a defined V(D)J rearrangement. JHΔ, 
allele formed by the targeted deletion of the joining cluster. S, Sγ3 switch region. IGHM, 
µ constant exon. VH additional 5′ variable sequence segments. DQ52, diversity 
sequence segment immediately 5′ of the joining sequence cluster. Arrows indicate 
transcriptional direction. Double bar denotes amplicon location. B. ChIPs identify 
monoubiquitinated histones with hypermutation. Murine splenocytes were cultured for 72 
hours with LPS, crosslinked, and then subjected to ChIP analysis with anti-mUb-H2A 
and anti-mUb-H2B, and anti-AID antibody. Normalized enrichment of the 17.2.25, Sγ3, 
triose phosphate isomerase (TPI) and neural-specific striatum-enriched protein-tyrosine 
phosphatase (STEP) loci from qPCR are shown relative to input DNA. C. Ethidium 
bromide visualization of traditional PCRs with primer sets corresponding to the qPCRs. 
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Figure 6. AID and Monoubiquitinated H2B Colocalize in Discrete Nuclear Foci. 
Representative immunofluorescence confocal microscopy images of Ramos cells 
stained for AID and mUb-H2B. Ramos cells were incubated with rabbit antibody specific 
to AID and murine mUb-H2B antibody followed by Alexa-488 conjugated rabbit 
secondary and Alexa-555 conjugated murine secondary antibody. Upper left, Ramos 
cells imaged with 488 nm filter. Upper right, Ramos cells imaged with 555 nm filter. 
Lower left, merged image with white scale bar (2 microns). Lower right nuclear envelope 
imaged using wheat germ agglutinin (Blue). Arrows point to colocalizations of AID and 
mUb-H2B. 
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Figure 7. PCNA and Polymerase Eta are Associated with the Ramos Re-VH 
Region. Ramos cells were crosslinked, and sheared chromatin subjected to 
immunoprecipitation using antibody specific to PCNA, MSH2 and polymerase eta, and 
non-specific IgG antibody. Precipitated template DNA was amplified by qPCR using 
primers specific to a control glutamine tRNA locus (tRNA), unrearranged VH (V8), and 
the rearranged VH (VH2)(see Figure 1). Enrichment using poly-specific IgG for each 
locus was subtracted to normalize for non-specific IP. Fold enrichment relative to input 
DNA is shown. 
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Figure 8. HEK293 and A549 ChIPs Using AID, MUb-H2A and MUb-H2B Antibodies 
Find No Enrichment of Sequences Undergoing Hypermutation in Ramos cells. 
Normalized template enrichment upon anti-AID, anti- mUb-H2A and anti-mUb-H2B 
ChIPs. Template obtained from IPs was amplified and analyzed by qPCR using primer 
sets diagramed in Figure 1. Results were normalized to non-specific IgG IP and relative 
to input. Each bar indicates the mean of the values obtained in triplicate with standard 
deviation. 
 
 
 
Figure 9. AID Antibody Used for ChIPs is Specific for AID. Western blot analysis of 
endogenous AID (24 kDa) in AID positive (Ramos) and in AID negative (HEK293) cell 
lysates. PCNA was utilized as load control. 
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Figure 10. AID IP Demonstrating AID Antibody Used for ChIPs is Detecting AID. 
Western blot analysis of endogenous AID (24 kDa) in Ramos cell lysate IP. Primary anti-
AID for IP, (Santa Cruz Biotechnology, Santa Cruz, CA sc-25620). Primary Ab for 
western, (Santa Cruz Biotechnology, Santa Cruz, CA sc-14680). Total supernatant and 
total IP were loaded to ensure equivalent starting material. 
 
 
 
Figure 11. MUb-H2b Colocalizes with AID in Multiple Discrete Foci. Representative 
immunofluorescence microscopy images of two distinct Ramos cells stained with AID 
and mUb-H2B antibodies and exhibiting colocalization of these at 1 (Panel A) and 2 
(Panel B) discrete foci. In each panel: Upper left, Ramos cells imaged with Alexa 488 
filter. Upper right, Ramos cells imaged with Alexa 555 filter. Lower left, merged images 
with white scale bar (2 microns). Lower right nuclear envelope imaged using wheat germ 
agglutinin (Blue). Arrows point to colocalizations of AID and mUb-H2B. 
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TABLE 
Table 1. Oligonucleotide Table. Oligonucleotide sequences for amplification of 
hypermutating genomic and control loci in this study are shown. 
 
Human QPCR Primers 
VH1 
VH1F CCCAAGGACACCCTCATGATCTCCC 
VH1R CATTATGCACCTCCACGCCGTCCAC 
VH2 
VH2/8F  GCAGGACTGTTGAAGCCTTCGGAG 
VH2R CTTACCTGAGGAGACGGTGACC 
VH3 
VH3F GACTAACCGGAGTTTCATGGCTGTGTTG 
VH3R GAGGTCTCAAACTTGATGGTTTGCAGATG 
V8 
VH2/8F   GCAGGACTGTTGAAGCCTTCGGAG 
V8R TGCAGGGAGGTTTTTGTCTGGG 
MYC1 
MYC1F   CCTCTCTCGCTAATCTCCGCCC 
MYC1R   CGCTCGCTCCCTCTGCCTCTC 
MYC2 
MYC2F CTGTATGTGGAGCGGCTTCTCG 
MYC2R CTGCTGTCGTTGAGAGGGTAG 
MYC3 
MYC3F CCACAGCAAACCTCCTCACAGCCCAC 
MYC3R CTCTGACACTGTCCAACTTGACCCTC 
MYC4 
MYC4F TCACCATCTTGACTCCTACCTTAGCC 
MYC4R CTGAACTGGCTTCTTCCCAGGAGCC 
β Actin 
bActF  GGCTCCGGCATGTGCAAGG 
bActR  GGTGAGGATGCCTCTCTTGCTCTG 
tRNAglu 
trna_glu_F AAGGCGCATCTCTAGTTCAGTGG 
trna_glu_R2 CTCTTTGCTCCTGGAGTCTCTCAC 
 
 
 
      Table Continues
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Mouse QPCR Primers 
STEP 
F2_neural_59.7 CCAGAGGACAGGCGTCAATCAG 
R1_neural_59.9 GTCAATGAGGCAGGATCAAGTCTCAGGTPI 
mus_tpi_2F61 CCTCTAGAACATTGATTGCTCTAGAACGCC 
mus_tpi_R61  TCAGTACAAACGCACGGCTCTCTC 
17.2.25 
F4_17.2.25_59 CTACAGGGGTCAATTCAGAGGTTCAG 
R1_17.2.25_63 GGCAGTGTCCTCAGATGTCAGGC         
Sγ3 
Sγ3F  AGTCACCATGTAGATACTCAGCCTG 
Sγ3R  CAGGTTATGCAGCTCCTGGGTCAG 
MYC MUTANT ANALYSIS 
Exon1 
MYC1F  CCTCTCTCGCTAATCTCCGCCC 
X1mutR  CACCATCTCCAGCTGGTCGGCC 
Exon2 
MYC2F  CTGTATGTGGAGCGGCTTCTCG 
MYC3R  CTCTGACACTGTCCAACTTGACCCTC 
Exon3 
X3mutF  CCACAGCATACATCCTGTCCGTCC 
X3mutR  CCTACCTCTCACCTTCTCACCTGCC
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CHAPTER III 
REPRESSION OF HUMAN ACTIVATION INDUCED CYTIDINE DEAMINASE 
BY MIR-93 AND MIR-155 
 
 
 
 
 
 
 
 
 
 
 
Contributions: 
The contents of this chapter were previously published and cited below. I 
contributed to all levels of experimentation with minor contributions to manuscript 
preparation and editing. 
Borchert, G. M., N. W. Holton, and E. D. Larson, 2011, Repression of human 
activation induced cytidine deaminase by miR-93 and miR-155: BMC 
Cancer, v. 11, p. 347. 
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ABSTRACT 
Activation Induced cytidine Deaminase (AID) targets the immunoglobulin 
genes of activated B cells, where it converts cytidine to uracil to induce 
mutagenesis and recombination. While essential for immunoglobulin gene 
diversification, AID misregulation can result in genomic instability and oncogenic 
transformation. This is classically illustrated in Burkitt's lymphoma, which is 
characterized by AID-induced mutation and reciprocal translocation of the c-MYC 
oncogene with the IgH loci. Originally thought to be B cell-specific, AID now 
appears to be misexpressed in several epithelial cancers, raising the specter that 
AID may also participate in non-B cell carcinogenesis. 
The mutagenic potential of AID argues for the existence of cellular 
regulators capable of repressing inappropriate AID expression. MicroRNAs 
(miRs) have this capacity, and we have examined the publically available 
human AID EST dataset for miR complementarities to the human AID 3'UTR. In 
this work, we have evaluated the capacity of two candidate miRs to repress 
human AID expression in MCF-7 breast carcinoma cells. 
We have discovered moderate miR-155 and pronounced miR-93 
complementary target sites encoded within the human AID mRNA. Luciferase 
reporter assays indicate that both miR-93 and miR-155 can interact with the 
3'UTR of AID to block expression. In addition, over-expression of either miR in 
MCF-7 cells reduces endogenous AID protein, but not mRNA, levels. Similarly 
indicative of AID translational regulation, depletion of either miR in MCF-7 cells 
increases AID protein levels without concurrent increases in AID mRNA. 
 52 
Together, our findings demonstrate that miR-93 and miR-155 
constitutively suppress AID translation in MCF-7 cells, suggesting widespread 
roles for these miRs in preventing genome cytidine deaminations, mutagenesis, 
and oncogenic transformation. In addition, our characterization of an obscured 
miR-93 target site located within the AID 3'UTR supports the recent suggestion 
that many miR regulations have been overlooked due to the prevalence of 
truncated 3'UTR annotations 
INTRODUCTION 
In antigen activated B cells the Activation Induced cytidine Deaminase 
(AID) protein is required for initiating mutagenesis and recombination of the 
immunoglobulin (Ig) genes to promote immunity. AID is a cytidine deaminase that 
converts single-stranded genomic cytidine into uracil, and its activity is 
pronounced at the Ig variable (V) and switch (S) regions (de Yébenes and 
Ramiro, 2006; Goodman et al., 2007; Longerich et al., 2006; Peled et al., 2008; 
Vallur et al., 2007). While spontaneously generated uracil in the genome is 
faithfully corrected as a part of normal DNA repair (Larson et al., 2008), AID-
induced uracils at the Ig loci are mutagenically resolved by multiple DNA repair 
factors (Peled et al., 2008; Stavnezer et al., 2008). Although AID targets the Ig 
loci in activated B cells, activity at other genomic sites has the potential to create 
oncogenic DNA damage. Indeed, transcribed genes across the genome have 
now been found to undergo AID deamination (reviewed by (Liu and Schatz, 
2009; Pérez-Durán et al., 2007), and recently, deep sequencing of AID-ChIPed 
template revealed broad AID-associations with expressed loci (Yamane et al., 
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2011). In addition, AID-dependent DNA breaks were recently identified within 
multiple types of repetitive elements (Staszewski et al., 2011) suggesting a broad 
ability for AID to target genomic regions harboring single-stranded character. 
AID misexpression results in DNA damage that promotes cancer (Liu et al., 
2008; Nagaoka et al., 2010; Okazaki et al., 2003; Parsa et al., 2007; Staszewski 
et al., 2011; Zhang et al., 2001). In lymphoid cells improper AID expression has 
been connected with mutations at c-MYC, PIM1, RhoH and PAX5 oncogenes, 
promoting diffuse large B cell lymphoma (Rossi et al., 2006). Similarly, Burkitt's 
lymphoma is characterized by AID-induced mutation and a reciprocal 
translocation between the c-MYC proto-oncogene and the IgH loci (Casellas et 
al., 2009; Pérez-Durán et al., 2007; Ramiro et al., 2004; Robbiani et al., 2008). 
While AID expression was initially thought to be B cell-specific, recent evidence 
indicates AID may promote the development of various non-lymphoid oncologies. 
In gastric cancer, the upregulation of AID leads to point mutations and copy 
number alterations of CDKN2A and CDKN2B tumor suppressor genes (Endo et 
al., 2011). In the same manner, AID misexpression in human colonic cells 
increases the mutation rate of TP53 by ~10-fold (Matsumoto et al., 2010). In 
addition, AID is expressed at various levels in ~1/3 of primary lung cancers 
(Shinmura et al., 2011) and in numerous breast cancer cell lines (Babbage et al., 
2006) where AID misexpression may be due in part to observations that estrogen 
is capable of inducing AID expression > 20 fold (Pauklin et al., 2009). Since 
errant AID activity can introduce significant genomic damage, the maintenance of 
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genome stability outside of the activated B cell environment likely depends upon 
multiple molecular AID restraints. 
Recent evidence suggests that one level of AID regulation comes from 
microRNAs (miRs). These short, ~20 nucleotide, noncoding RNAs can regulate 
networks of genes and function by repressing translation or directing mRNA 
destruction through partial sequence complementarity to 3' untranslated regions 
(3'UTRs) of mRNAs (Lau et al., 2001; Lee and Ambros, 2001). MiRs are key 
regulators of cellular differentiation, proliferation and apoptosis, and aberrant miR 
expression has been associated with a myriad of human diseases, including 
cancer (reviewed by (Farazi et al., 2011). A subset of miRs typically 
misexpressed in malignancy (oncomiRs) can function as oncogenes or tumor 
suppressors with impacts on cellular transformation and metastasis. One such 
oncomiR, miR-155, represses murine AID, and the disruption of the miR-155 
recognition site or miR-155 itself results in increased AID-induced c-
MYC translocation (Dorsett et al., 2008) and BCL6 mutagenesis (Teng et al., 
2008). This may provide one explanation for why disruption of miR-155 is 
associated with Burkitt's lymphoma (Kluiver et al., 2006) and suggests the 
existence of parallel miR repressions in humans. 
In order to better define the regulators of human AID in cells other than 
antigen-activated B cells, we examined the 3'UTR of human AID for miR 
complementarities. Consistent with the role of miR-155 in regulating AID in mice 
(Dorsett et al., 2008; Teng et al., 2008), we find a moderate miR-155 site in 
human AID. Surprisingly, we also find a previously uncharacterized, yet 
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exceptional, complementarity to miR-93 in the AID 3'UTR. We show both of 
these miRs interact with the AID 3'UTR in the cell to regulate its translation, and 
that loss of either miR results in increased AID protein levels. Based on the 
involvement of AID in generating oncogenic genome mutations, our results 
suggest that miR-93 and miR-155 act as dual genome sentries to prevent errant 
translation of AID mRNA. 
RESULTS 
The Human AID 3'UTR Contains Sequences Complementary to MiR-93 and 
MiR-155 
In light of the evidence supporting AID regulation by miR-155 in mouse 
showing miR-155 regulates AID translation and c-myc translocation (Dorsett et 
al., 2008; Teng et al., 2008), we asked if human AID is regulated by similar 
microRNA interactions. Computational analysis of the human AID 3'UTR 
revealed a human miR-155 target site, consistent with studies in mice (Dorsett et 
al., 2008; Teng et al., 2008). To our surprise, we also found pronounced 
complementarity between the AID 3'UTR and miR-93 (Figure 12). This miR-93 
target site is markedly more extensive than the majority of characterized 
miR::mRNA interactions containing only a single, centrally located 4 base pair 
mismatch. Strikingly, we find the predicted binding affinity between miR-93 and 
the AID 3'UTR (-30.3 kcal/mole) to be nearly double that of miR-155 (-15.3 
kcal/mole) (Figure 12A) suggesting a strong post-transcriptional regulatory 
relationship. Further analysis of the human AID 3'UTR revealed an internal 20 nt 
stretch of adenosines (sufficient for cDNA poly-T priming) separating the miR-
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155 and miR-93 target sites (Figure 12A). This false polyA is located ~1,000 nt 3' 
of the AID stop codon and does not correspond to the full length cDNA 
polyadenylation as: (1) it is not preceded by the canonical 5' AAUAAA poly 
adenylation signal or other recognizable alternative poly adenylation signal, and 
(2) the miR-93 target site is expressed in both Ramos and MCF-7 cells  (Figure 
12B). Importantly, examination of publically available EST datasets confirms this 
internal polyA stretch has repeatedly served as an oligo-dT priming site for EST 
reverse transcriptase leading to the improper annotation of a 
truncated AID cDNA (for example see NCBI accessions GI:33871601 and 
GI:50496022). We conclude that the human AID 3'UTR contains miR-155 and 
miR-93 recognition sites, which are separated by a 20 nucleotide adenosine 
repeat upstream from the true polyA sequence. 
MiR-93 and MiR-155 Interact with the AID 3'UTR to Inhibit its Expression 
The identification of miR-93 and miR-155 binding sites in the 3'UTR of 
human AID strongly suggests post-transcriptional regulatory interactions. 
Therefore, we next asked if miR-93 and miR-155 were capable of regulating 
the AID 3'UTR using standard luciferase reporter assays. Three expression 
constructs incorporating an endogenous human microRNA Alu promoter were 
created by cloning the endogenous miR-517a genomic locus and then replacing 
the miR-517a hairpin with the miR-93, miR-155 and shLacZ hairpins (pAL-93, 
pAL-155, and pAL-1 respectively) (Figure 13A), as described (Borchert et al., 
2006). We also generated 3'UTR reporter constructs to testAID::miR regulatory 
interactions. These reporters (AID 3'LR and Ctl 3'LR) produce Renilla luciferase 
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transcripts tailed with the AID 3'UTR and shLacZ target sequence respectively 
(Figure 13). Co-transfection of human embryonic kidney (HEK293) cells with 
pAL-93 and AID 3'LR constructs resulted in ~80% knockdown of Renilla 
luciferase intensity, whereas co-transfection of pAL-155 and AID 3'LR constructs 
resulted in ~60% knockdown of Renilla luciferase intensity at a 4:1 transfection 
ratio (Figure 13C). Similarly and as expected, co-transfection of pAL-1 and Ctl 
3'LR resulted in a reduction of Renilla luciferase intensity with ~95% knockdown 
(Figure 13D). In contrast and as expected, neither the co-transfection of pAL-1 
with AID 3'LR nor co-transfection of either miR construct with Ctl 3'LR resulted in 
silencing (Figure 13C, D). To further ensure the repressions of AID 3'LR by pAL-
93 and pAL-155 were due to specific interactions between miRs -93 and -155 
and their proposed target sites in the AID 3'UTR, we constructed two additional 
luciferase reporters whose 3'UTRs consisted of: (1) the two target sites with 
intervening sequence removed and (2) scrambled versions of the two target sites 
with intervening sequence removed. Again, we found co-transfection of human 
embryonic kidney (HEK293) cells with pAL expression constructs and a 
luciferase reporter containing intact miR target sites resulted in significant 
repression of Renilla luciferase in contrast to control transfections of scrambled 
miR target site reporters, which were not repressed (Figure 17). Therefore, miR-
93 and miR-155 facilitate molecular interactions with the AID 3'UTR sufficient to 
repress translation. 
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MiR-93 and MiR-155 can Repress Endogenous AID 
Interactions between miR-93, miR-155 and the AID 3'UTR within the 
context of our reporter assays (Figure 13C, D) strongly support the involvement 
of both miRs in AID translational regulation. If so, we anticipated that if miR-93 
and/or miR-155 were present in AID expressing cells they could suppress 
endogenous AID protein levels. We therefore asked if miR-93 and miR-155 are 
present in two cell lines known to express AID, Ramos and MCF-7. Ramos is a B 
cell line that undergoes constitutive AID-induced somatic hypermutation (Sale 
and Neuberger, 1998), and MCF-7 is a breast carcinoma that misexpresses AID 
(Babbage et al., 2006). Using standard RT-PCR analysis, we found miR -93 and 
-155 transcripts are expressed in both cell lines (Figure 18), consistent with the 
ubiquitous expression documented for both of these miRs (Landgraf et al., 2007). 
In order to determine if endogenous AID can be repressed by increased miR-93 
and/or miR-155 expression, we introduced pAL miR over-expression plasmids 
(Figure 13A) into MCF-7 cells (Borchert et al., 2006). Importantly, overexpression 
of miR-93, miR-155, or an AID-targeting siRNA (shAID) in MCF-7 cells each 
reduced AID protein levels between 70 and 90%, whereas overexpression of the 
pAL-1 control did not significantly alter AID expression (Figure 14A). To ensure 
results were the consequence of miR regulation, we confirmed the miR-93 
repression of AID was dose-dependent (Figure 19) and isolated total RNA from 
each of our transfections to monitor AID mRNA levels by quantitative PCR. 
Strikingly, while shAID transfection averaged a 92% reduction of AID mRNA 
levels, neither pAL-93 nor pAL-155 transfection resulted in significant reduction 
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of AID mRNA (Figure 14B) confirming that the observed reductions in AID protein 
levels following their transfections are mediated through translational repression. 
To summarize, our results demonstrate that the decreases in AID protein upon 
shAID transfection were due to message degradation, whereas pAL-93 and pAL-
155 overexpression resulted in miR-mediated translational repression. 
Endogenous MiR-93 and MiR-155 Restrain AID Protein Translation 
Over-expression of miR-93 and miR-155 repressed the expression of 
endogenous AID, supporting the model that both miRs contribute to post-
transcriptional regulation of AID. To be consistent with that hypothesis, the loss 
of cellular miR-93 or miR-155 should result in higher AID expression. Therefore, 
we depleted miR-93 and miR-155 individually and then monitored changes to 
AID protein levels by western blotting. To achieve this, we constructed miR 
sponge transgenes for miR-93 and miR-155 that function by competitively 
inhibiting miR activity, as previously described (Ebert et al., 2007; Ebert and 
Sharp, 2010). Our miR sponge transgenes produce RNAs containing ~10 copies 
of the miR-93 or miR-155 AID 3'UTR complementary binding sites (Figure 15A). 
Individual miR sponges or a negative control sponge transgene were transiently 
transfected in MCF-7, and relative AID protein levels measured by western. 
MCF-7 cells expressing either miR-93 or miR-155 sponges showed clear dose-
responsive increases in AID protein levels, whereas control transfections did not 
significantly alter AID protein expression (Figure 15B). To ensure these findings 
were the consequence of restricted miR activity, we isolated total RNA from each 
of our transfections and examined AID mRNA levels by quantitative PCR. We 
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found AID mRNA levels largely unaffected by transfection of sponge constructs 
further supporting endogenous roles for these miRs in the restraint of AID 
translation (Figure 15C). We conclude that one function of endogenous miR-93 
and miR-155 expression is to restrict the translation of AID mRNA. 
DISCUSSION 
Model for AID Repression 
We have shown that miR-93 and miR-155 have the capacity to repress 
AID translation and do so in the cellular context. Overexpression of miR-93 or 
miR-155 reduced AID protein levels in MCF-7 breast cancer cells (Figure 14A), 
whereas depletion of either endogenous miR-93 or miR-155 resulted in 
increased AID translation (Figure 15) directly connecting miR expression with 
changes in AID protein concentration. Based on our findings, we propose a 
model for the relationship between miRs -93 and -155 and AID regulation in 
maintaining genomic integrity (Figure 16). In cellular circumstances where high 
levels of AID transcription exist (such as antigen activated B cells or some 
established cancers) AID mRNA levels overwhelm miR controls. In these 
situations, endogenous miR-155 and miR-93 have negligible influence on AID 
protein levels. In contrast, miR-93 and miR-155 can greatly reduce the potential 
for errant AID expression which protects the genome from unwanted cytidine 
deamination and mutation by restricting AID protein production (Figure 16). This 
may be particularly important during S-phase when replication transiently 
denatures the DNA. Conspicuously, miR-93 is intronically encoded within the 
minichromosome maintenance 7 (MCM7) gene, an essential replication licensing 
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factor, and precursor miR-93 abundance tracks with MCM7 expression levels 
(Long et al., 2010; Petrocca et al., 2008). It is therefore tempting to speculate that 
domestication of the miR-93 microRNA along with the corresponding AID 3'UTR 
site occurred as a response to the selective pressure for maintaining genome 
fidelity during replication. 
Disruptions of MiR-155 and MiR-93 are Associated with AID-Induced 
Oncogenesis 
Highlighting the importance of tightly controlled AID expression, novel AID 
regulations continue to be described. In 2008, miR-155 was identified as an 
important repressor of AID translation in mice, and loss of this regulation is 
lymphomagenic  (Dorsett et al., 2008; Teng et al., 2008). Our data now 
demonstrate directly that expression of endogenous miRs -93 and -155 
represses AID translation in MCF-7 breast cancer cells. While a direct correlation 
between miR-93 activity and AID-induced oncogenesis remains to be described, 
miR-93 perturbations have been found to enhance cell survival, possess 
oncogenic activities, and augment tumor growth through regulating integrin-β8, 
the tumor suppressor gene FUS1, the Cdk inhibitor p21, and tumor protein 53-
induced nuclear protein 1 (TP53INP1) (Du et al., 2009; Fang et al., 2011; Kim et 
al., 2009; Yeung et al., 2008). Our results suggest that in addition to these known 
oncogene regulations, loss of miR-93 (or miR-155) may permit AID upregulation 
and mutator phenotypes in non-B cell oncologies (e.g. breast, colon, stomach 
and lung (Babbage et al., 2006; Endo et al., 2011; Matsumoto et al., 2010; 
Shinmura et al., 2011). However, it is possible that additional miR AID 
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regulations may still be described, and our research does not seek to eliminate 
other potential regulators. 
MicroRNA Target Sites Obscured by Repetitive Element Insertions 
Our identification of an extensive and uncharacterized 3'UTR for 
human AID reveals the presence of sequence elements that may confound miR 
regulatory relationships for other mRNAs. We find that the AID 3'UTR is ~1000 nt 
longer than previously annotated likely due to mispriming from an internal stretch 
of 20 adenosines. The full length AID 3'UTR contains a previously unidentified 
regulatory sequence, an unusually pronounced miR-93 complementarity (Figure 
12), conferring marked repression to targeted transcripts (Figure 13 and 17). 
Clearly, this finding agrees with recent suggestions that cryptic miR 
complementarities may actually be quite common with nearly 50% of human and 
mouse 3'UTRs likely extending well beyond their annotated termini (Djebali et al., 
2008; Thorrez et al., 2010). Since 3'UTRs contain miR binding sites, our analysis 
of AID is consistent with the notion that other miR posttranscriptional regulations 
may have been overlooked because of truncated 3'UTR annotations. This may 
be particularly pronounced in humans as 5-10% of all human 3'UTRs contain at 
least one Alu repeat, a common miR-associated retro-element characterized by a 
central 10-40 nt adenosine linker (Borchert et al., 2009; Borchert et al., 2006; 
Häsler et al., 2007; Jurka and Gentles, 2006; Lehnert et al., 2009; Mighell et al., 
1997; Smalheiser and Torvik, 2006; Yulug et al., 1995). 
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CONCLUSION 
In the present study, two human microRNAs, miR-155 and miR-93, were 
each shown to repress the translation of human AID through interactions with the 
AID 3'UTR in the MCF-7 breast carcinoma cell line which aberrantly expresses 
AID. Together, our data suggest that low-level errant AID expression and 
subsequent genome damage may be prevented through protective miR-93 
and/or miR-155 regulation. In addition, our identification of a miR-93 target site 
for AID located downstream of an internal adenosine repeat highlights the 
possibility that other miR regulations may have been overlooked because of 
truncated 3'UTR annotations. 
MATERIALS AND METHODS 
Reagents and Cell Lines 
Oligonucleotide sequences are detailed in Table 1. Human embryonic 
kidney (HEK293) cell line was obtained from GenLantis (San Diego, CA), 
Burkitt's lymphoma (Ramos) and breast cancer (MCF-7) cells were both 
purchased from the American Type Culture Collection, (ATCC, Manassas, VA). 
HEK293 and MCF-7 cells were cultured in MEM (Mediatech, Herndon, VA) 
supplemented with 10% fetal bovine serum (Hyclone, Logan, UT). Ramos cells 
were cultured in RPMI (Mediatech) supplemented with 10% fetal bovine serum 
(Hyclone, Logan, UT). All tissue culture media were supplemented with 25 mg/ml 
streptomycin and 25 I.U. penicillin (Mediatech). Cells were cultured in a 
humidified atmosphere with 5% CO2 at 37°C. For luciferase assays, HEK293 s 
were cultured in MEM (10% FBS and 1% PS) in 12-well plates. At 90% 
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confluency, cells were transfected following the Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA) protocol. At 35 h, existing media was replaced with 1 ml fresh 
media. For miR expression assays, MCF-7 s were cultured in MEM (10% FBS 
and 1% PS) in 6-well plates. At 90% confluency, cells were transfected following 
the Lipofectamine 2000 (Invitrogen) protocol and harvested after 48 h. For miR 
sponge assays, MCF-7 s were cultured in MEM (10% FBS and 1% PS) in 6-well 
plates. At 70% confluency, cells were transfected following the Lipofectamine 
2000 (Invitrogen) protocol. At 48 h, existing media was replaced with 2 ml fresh 
media and cell transfections were repeated as initially performed. Cells were then 
harvested after an additional 48 h culture. 
Luciferase Assays 
At 36 h post transfection, cells were scraped from well bottoms and 
transferred to 1.5 ml Eppendorf tubes. Eppendorfs were centrifuged at 2000 RCF 
for 3 min, followed by supernatant aspiration and cell resuspension in 300 μl of 
PBS. Cells were lysed by freeze thaws and debris removed by centrifuging at 
3000 RCF for 3 min. 50 μl of supernatant was transferred to a 96-well MicroLite 
plate (MTX Lab Systems, Vienna, VA) then firefly and Renilla luciferase activities 
measured using the Dual-glo Luciferase® Reporter System (Promega, Madison, 
WI) and a 96-well plate luminometer (Dynex, Worthing, West Sussex, UK). RLUs 
were calculated as the quotient of Renilla/firefly RLU and normalized to mock. 
Western Blotting 
MCF-7 cells (at ~1 × 106 cells/ml) were pelleted by centrifugation, existing 
media removed, and cells resuspended in SDS lysis buffer containing protease 
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inhibitors and transferred to 1.5 ml Eppendorf tubes. Proteins were 
electrophoresed through a 4-12% SDS-polyacrylamide gradient gel (Invitrogen) 
and transferred to immobilon-P PVDF membranes (Millipore, Temecula, CA). 
Membranes were blocked for 1 hour in 5% (w/v) nonfat milk in phosphate-
buffered saline containing 0.05% Tween 20, washed, and incubated with primary 
antibody overnight at 4°C using the following dilution: anti-AID (Santa Cruz 
Biotechnology, Santa Cruz, CA, sc-25620) - 1:500 and anti-PCNA (Santa Cruz) - 
1:10000. Membranes were washed and incubated with secondary Abs: HRP 
conjugated goat anti-mouse and goat anti-rabbit (Invitrogen) at 1:10000 dilution. 
Immunoreactive bands were visualized with ECL Plus (GE, Piscataway, NJ) and 
signals were detected by using the Storm 840 PhosphorImager and 
IMAGEQUANT software (GE). 
Vector Construction 
Unless otherwise indicated, PCR amplifications were performed in 40 μl 
reactions at standard concentrations (1.5 mM MgCl2, 0.2 mM dNTP, 1× Biolase 
PCR buffer, 0.5 U Taq (Bioline USA, Inc., Randolph, MA), 0.5 uM each primer) 
and using standard cycling parameters (94°C - 3 min, (94°C - 30 s, 55°C - 30 s, 
72°C - 60 s) × 30 cycles, 72°C - 3 min) then cloned into Topo PCR 2.1 
(Invitrogen). RT-PCRs were performed at 65°C using MonsterScript Reverse 
Transcriptase (#MSTA5110, Epicentre, Madison, WI) and gene specific or 
random nonamer primers. Resultant amplicons were cloned into Topo PCR 2.1 
and sequenced. Antisense reporter, Ctl 3'LR, was constructed by oligonucleotide 
primer extension (25 cycles with 10 s extensions) with primers containing 5' Xho-I 
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and 3' Spe-I restriction enzyme sites immediately flanking sequences perfectly 
complementary to mature siLacZ. Antisense reporter, AID 3'LR, was constructed 
by standard PCR with primers containing 5' Xho-I and 3' Spe-I restriction enzyme 
sites. Following digestion, amplicons were ligated into the Renilla luciferase 
3'UTR of psiCheck2 (Promega) vector linearized with Xho-I and Spe-I. The 
presence of an independently transcribed firefly luciferase in these reporters 
allowed normalization for transfection efficiency. Sponge expression constructs 
were generated by concatamerizing PCR using the primers indicated in, Table 1. 
Resulting amplicons were separated on a 1% agarose gel and a band excised 
from the appropriate lane at ~400 bp. Gel extractions were cloned into Topo PCR 
2.1 and sequenced. Concatamers were next excised from Topo PCR 2.1 and 
cloned into the pEGFP expression vector (Clontech, Mountain View, CA) using 
BamHI and Not I restriction sites. 
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FIGURES 
 
Figure 12. The AID 3'UTR. (A) Cartoon of AID 3'UTR miR target sites (TS) and internal 
(False) polyA (not to scale) (DNA sequence shown). MicroRNA alignments are shown 
with corresponding binding affinities (kcal/mol). Vertical lines indicate complementary 
base pairing. Dotted vertical lines indicate G:U base pairing. PolyA, AATAAA eukaryotic 
polyadenylation signal. Arrows indicate RT-PCR primer sets for confirmation of 
expression. (B) RT-PCR to test expression of the AID 3'UTR miR-155 and miR-93 target 
site (TS) sequences in Ramos and MCF-7 cells. 
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Figure 13. The AID 3'UTR is Recognized by MiRs-93 and -155. (A) Diagrams of miR 
and siRNA expression vectors. 5'Alu corresponds to a genomic fragment containing the 
miR-517a upstream Alu promoter. In pAL-1, shLacZ replaces the miR-517a hairpin. In 
pALs-155 and -93, the pre-miR-155 and -93 hairpins replace the miR-517a hairpin 
respectively. TTTT, RNA polymerase III termination signal. (B) Diagrams of luciferase 
reporters. The AID 3'UTR luciferase reporter (AID 3'LR) and control 3'UTR luciferase 
reporter (Ctl 3'LR) were generated respectively by placing anAID 3'UTR sequence 
containing both the miR-155 and miR-93 target sites and a specific region of LacZ 
previously shown to be targeted by the pAL-1 shLacZ hairpin in a multiple cloning site in 
the Renilla luciferase 3'UTR. HSV-TKp, herpes simplex virus thymidine kinase promoter; 
SV40p, simian virus 40 promoter; FF Luc, firefly luciferase; Ren Luc, Renilla luciferase; 
pA, poly(A). (C) AID 3'LR is specifically repressed by both miR-93 and miR-155 in 293 
transient transfections. Luciferase assays (n = 4) of HEK293 lysates after transfection of 
AID 3'LR and either pAL-1, pAL-155 or pAL-93. Transfections were normalized to AID 
3'LR alone. RLU, relative light units. (D) Ctl 3'LR is specifically repressed by the ctl (pAL-
1) in 293 transient transfections. Cotransfections done as in (C), except Ctl 3'LR 
replaced AID 3'LR. 
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Figure 14. MiR-93 and MiR-155 Can Repress Endogenous AID. (A) Representative 
western demonstrating that transient transfection of pAL-93, pAL-155 and shAID 
expression constructs repress endogenous AID protein levels in MCF-7 cells. ShAID 
produces an AID-targeting siRNA from a pAL-driven hairpin expression vector as in 2A. 
Ctl, pAL-1 transfected; PCNA, Proliferating Cell Nuclear Antigen load control. (B) 
Relative AID mRNA levels corresponding to replicate transfections performed as in A (n 
= 3) as determined by quantitative PCR. 
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Figure 15. Endogenous MiR-93 and MiR-155 Restrain AID Protein Expression. (A) 
Diagram of miR sponge expression vector. TS indicates an AID 3'UTR miR target site 
detailed in 1A. The miR-93 sponge produces a polyadenylated concatamer of 11 
individual 93 TSs. Analogously designed, the miR-155 sponge contains 10 individual 
miR-155 TSs, and the ctl sponge contains 14 individual shLacZ targets. CMVp, 
immediate early cytomegalovirus promoter; SV40pA, simian virus 40 polyadenylation 
signal. (B) Representative western demonstrating that transient transfection of MCF-7 
cells with the miR-93 or miR-155 sponges results in dose responsive increases in AID 
protein levels as compared to control. Ctl, shLacZ target site sponge transfected; PCNA, 
Proliferating Cell Nuclear Antigen. (C) Relative AID mRNA levels corresponding to 
replicate transfections performed as in B (n = 3) as determined by quantitative PCR. 
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Figure 16. Model of MiR-93 and MiR-155 Regulation of AID Mediated Genomic 
Instability. In normal cells, top, genome stability is maintained by inhibition of AID 
translation by miR-93 and/or miR-155 when AID mRNA levels are low. Bottom, in 
antigen activated B cells or when misregulated, levels of AID mRNA exceed the capacity 
for miR translational repression. AID translation results in AID protein levels that support 
Ig gene diversification, mutagenesis and genome instability. 
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Figure 17. The AID 3'UTR is Recognized by MiRs -93 and -155. (A) The AID 3'UTR 
recognition by miRs -93 and -155 is specific. (A) Diagrams of luciferase reporters. The 
AID 3'UTR luciferase reporter (TS Intact) and control 3'UTR luciferase reporter (TS 
Scram) were generated respectively by placing the AID 3'UTR miR -93 and -155 target 
sites (TS Intact)(with intervening sequences deleted) or an identical sequence in which 
the target site nucleotides had been scrambled (TS Scram) into a multiple cloning site in 
the Renilla luciferase 3'UTR [32]. HSV-TKp, herpes simplex virus thymidine kinase 
promoter; SV40p, simian virus 40 promoter; FF Luc, firefly luciferase; Ren Luc, Renilla 
luciferase; pA, poly(A); 155TS, miR-155 target site; 93TS, miR-93 target site; 155SC, 
miR-155 target site scrambled; 93SC, miR-93 target site scrambled. (B) TS Intact is 
specifically repressed by both miR-93 and miR-155 in 293 transient transfections. 
Luciferase assays (n = 9) of HEK293 lysates after transfection of TS Intact and either 
pAL-1, pAL-155 or pAL-93. Transfections were normalized to TS Intact alone. RLU, 
relative light units. (C) TS Scram is unaffected by co-transfection of pAL-1, pAL-155 or 
pAL-93 in 293 transient transfections. Cotransfections done as in B, except TS Scram 
replaced TS Intact.  
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Figure 18. MicroRNAs MiR-93 and MiR-155 are Widely Expressed. RT-PCR of pre-
miR template in three different cell lines, HEK293 embryonic kidney cells, MCF-7 breast 
cancer line, and Ramos Burkitt's lymphoma line. (top) RT-PCR products of the miR-93 
locus amplified from indicated cellular RNAs. m, miR-93; β, Beta actin positive control; - 
Ctl, no template. (bottom) RT-PCR products of the miR-155 locus amplified from 
indicated cellular RNAs. Annotations are same as above except (m) denotes pre-miR-
155 amplicon. PCR of source RNAs failed, indicating above RT-PCRs templated from 
the generated cDNA. 
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Figure 19. MiR-93 Represses Endogenous AID in a Dose Responsive Manner. (A) 
Representative western demonstrating that transient transfection of pAL-93 expression 
constructs repress endogenous AID protein levels in MCF-7 cells in a dose responsive 
manner. (B) Relative AID mRNA levels corresponding to replicate transfections 
performed as in A (n = 2) determined by quantitative PCR. 
 
 
 
  
81 
TABLE 
 
Table 2. Oligonucleotide Master List. All oligonucleotides were synthesized 
commercially (Fisher, Operon) at either 25 or 100 nM scale. pAL refers to the 
human miR-517a Alu promoter. 93 and 155 refer to human miRs. TS refers to a 
siRNA or miR target site. lowercase indicates imperfect antisense, AID 3'LR was 
generated using TS-155F and TS-93R. 
 
pAL Construct Primers  
5’Alu Forward  CCCAAGGACACCCTCATGATCTCCC  
3’pAL-93R 
AAAAACTCGGGAAGTGCTAGCTCAGCAGTAGGTTGGGTAATCACACTACCT
GCACGAACAGCACTTTGGAGTGGATATCTGCAGAATTCG  
3’pAL-155R 
AAAAAACTGTTAATGCTAATATGTAGGAGTCAGTTGGAGGCAAAAACCCCTA
TCACGATTAGCATTAACAGGGATATCTGCAGAATTCG  
3’pAL-1R3 
AAAAACGTGACCTATCCCATTACGTGACAGGAAGCGTAATGGGATAGGTCA
CGTTGATGGATATCTGCAGAATTCG  
3’pAL-shAIDr 
AAAAAAAAATGTCCGCTGGGCTAAGGTGACAGGAAGCCTTAGCCCAGCGGA
CATTTGATGGATATCTGCAGAATTCG  
Sponge Construct Primers  
93 Sponge  
Gb130SPG93TSf   
TGAATATAACGCCTGTAATCCCAGCACTTTGGGAGGTGAATATA  
Gb131SPG93TSr  
TATTCACCTCCCAAAGTGCTGGGATTACAGGCGTTATATTCACC  
155 Sponge  
Gb132Spg155TSf  
GGTGAATATATGGGGATAGTGCTAATCGTAATTGGTGAATATA  
Gb133Spg155TSr  
TATATTCACCAATTACGATTAGCACTATCCCCATATATTCACC 
 
 
      Table Continues
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Sponge Control1  
Gb140spgsiLacZ5p10f   
GTGAATATATTAATACGTGACCTATTaaTGGTGAATATA  
Gb141spgsiLacZ5p10r   
TATATTCACCAttAATAGGTCACGTATTAATATATTCACC  
AID 3’UTR Target Sites and Reporter Primers 
MiR-93-TS  
TS-93F   GGAAGGAAGTTGCTTGAATGTTGG  
TS-93R2 GAGACAGAGTCTTGCTCTTGTCG           
MiR-155-TS TS-155F2  CCTGGGAGCATCCTAAAGTGTCAAC  
TS-155R  TCTTGTTCACAGTCCTCCTGCCC  
Ctl 3’LR3 LacZ_TS_F 
TTCTCGAGCGGTTACGATGCGCCCATCTACACCAACGTGACCTATCCCATTA
CGGTCAA  
LacZ_TS_R 
AAGCGGCCGCGGGAACAAACGGCGGATTGACCGTAATGGGATAGGTCACG
TTGGTGT  
TS Intact  
TSIntactF 
AAACTCGAGTGATTGTGACCCCAAACCATCTCTCCAAAGCATTAATATCCAA
TCATGCGCGGCGTGGTGGCTC  
TSIntactR 
TTTGCGGCCGCGCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCC
ACCACGCCGCGCATGATTGG  
TS Scram  
TSScramF 
AAACTCGAGTGATTGTGACCCCATCTATCAATCAACCTAAGAACTCATCCAA
TCATGCGCGGCGTGGTGGCTC  
TSScramR 
TTTGCGGCCGCGCTCGGCCTCGGTTGAACGGTAACGGCAGACTCTGAGCC
ACCACGCCGCGCATGATTGG  
RT-PCR Primers for miR Expression  
Pre-miR-93  
miR-93F GAGATGAGGCGAGAGGCTTGGG  
miR-93R CCTTTGACATCTCCATTAGCCTGATGG  
Pre-miR-155 
 miR-155F GCCTCCAACTGACTCCTACATATTAGC  
miR-155R GTTTAAGGTTGAACATCCCAGTGACCAG  
 
      Table Continues 
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β Actin  
gb204_bAct2F2_62 CCAACCGCGAGAAGATGACCC  
gb205_bAct2R1_61 CTCCTTAATGTCACGCACGATTTCCC  
Quantitative PCR Primers  
AID  
AID-F GTGACCCCAAACCATCTCTCCAAAGC  
AID-R TCCCCAACATTCAAGCAACTTCCTTCC  
β Actin  
bActF GGCTCCGGCATGTGCAAGG  
bActR GGTGAGGATGCCTCTCTTGCTCTG           
tRNAglu  
trna_glu_F AAGGCGCATCTCTAGTTCAGTGG  
trna_glu_R2 CTCTTTGCTCCTGGAGTCTCTCAC 
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CHAPTER IV 
G-QUADRUPLEX DNA STRUCTURES CAN INTERFERE WITH URACIL 
GLYCOSYLASE ACTIVITY IN VITRO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contributions: 
The contents of this chapter have been submitted to the journal Mutagenesis and 
the manuscript is currently under review for acceptance and publication (October 
2015). I performed all experimentation and fully prepared the manuscript with 
Erik Larson. 
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ABSTRACT 
Genome sequences that contain tandem repeats of guanine can form 
stable four-stranded structures known as G-quadruplex, or G4 DNA.  While the 
molecular mechanisms are not fully defined, such guanine-rich loci are prone to 
mutagenesis and recombination. Various repair pathways function to reduce the 
potential for genome instability by correcting base damage and replication errors; 
however, it is not yet fully defined how well these processes function at G4 DNA. 
One frequent form of base damage occurs from cytidine deamination, resulting in 
deoxyuracil and UG mismatches. In duplex and single-stranded DNA, uracil 
bases are recognized and excised by uracil glycosylases. Here, we tested the 
efficiency of uracil glycosylase activity in vitro on deoxyuracil bases located 
directly adjacent to guanine repeats and G4 DNA. We show that uracil excision 
by bacterial UDG and hUNG2 is reduced at uracils positioned directly 5’ or 3’ of a 
guanine tetrad. Control reactions using oligonucleotides disrupted for G4 
formation or reaction conditions that do not favor G4 formation resulted in full 
uracil excision activity. Based on these in vitro results, we suggest that folding of 
guanine-rich DNA into G4 DNA results in a DNA conformation that is resistant to 
uracil glycosylase-initiated repair, and this has the potential to increase the risk of 
instability at guanine repeats in the genome. 
INTRODUCTION 
Guanine-rich and repetitive genomic DNA has the unique ability to adopt 
four-stranded conformations called G4 DNA, and the impact of those structures 
on DNA metabolism is important for clarifying the molecular sources of genetic 
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disease (Bochman et al., 2012; Maizels, 2015; Tarsounas and Tijsterman, 2013). 
Physiological salt and pH conditions promote G4 folding into structures built from 
stacks of guanine “tetrads”, each of which is composed of four guanine bases 
paired to each other via Hoogsteen bonds (Sen and Gilbert, 1988, 1990). The 
specific conformation and overall stability of a given G4 is influenced by the 
sequences, ions, and reaction conditions (Burge et al., 2006). In higher 
eukaryotes, G4 sequences are located at sites of programmed recombination 
and at a variety of unstable intergenic regions where G4 structure formation 
promotes site-specific instability and disease (Cea et al., 2015; Davis and 
Maizels, 2011; Maizels, 2015). Of particular note are G4-capable sequences 
enriched at oncogenes, where G4 structure formation may contribute to gene 
regulation and oncogenesis (Eddy and Maizels, 2006). G4 structures have been 
shown to form from guanine-repeat sequences at rearrangements sites, such as 
the HOX11 (Nambiar et al., 2013), BCL2 (Nambiar et al., 2011), and TCF3 
(Williams et al., 2015) cancer-related genes.  
When DNA becomes transiently denatured during transcription or 
replication guanine-rich and repetitive DNA is freed from the complement and 
permitted to adopt structures like G4, where they can subsequently interfere with 
various DNA metabolic pathways (Bochman et al., 2012; Brooks et al., 2010; 
Tarsounas and Tijsterman, 2013; van Kregten and Tijsterman, 2014; Wu and 
Brosh, 2010). This raises the possibility that some DNA repair activities may be 
inhibited at G4 DNA, contributing to the apparent instability that characterizes 
many guanine-rich loci. One major pathway, base excision repair (BER), reduces 
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mutagenesis by correcting bases that were damaged by deamination or oxidation 
(Krokan and Bjørås, 2013; Krokan et al., 2014). BER is initiated by a lesion-
specific glycosylase that removes the damaged base, followed by excision of the 
resulting abasic site to permit subsequent resynthesis to reconstitute the original 
base pairing. Emerging evidence suggests that some DNA lesions in G4 DNA 
may not be processed efficiently by BER. In telomeric G4, activity assays have 
shown that 8-oxoguanine is not excised by human glycosylases, even though 
further oxidation products can be processed (Zhou et al., 2015; Zhou et al., 
2013). The APE1 enzyme, which cleaves abasic sites, was also shown to have 
reduced enzymatic activity at abasic sites residing within certain G4 DNA 
structures (Broxson et al., 2014; Zhou et al., 2015). These findings support the 
model that G4 DNA can interfere with DNA correction activities, and could 
therefore contribute to mutagenesis at guanine-rich loci by reducing DNA repair 
efficacy at those sites.  
Here we asked if G4 DNA interferes with excision of a common form of 
DNA damage, deaminated cytidine (deoxyuracil), by uracil DNA glycosylase in 
vitro. Using synthetic oligonucleotide substrates, we placed a single deoxyuracil 
either directly 3’ or 5’ of a guanine repeat sequence or in between repeats, and 
then measured the activities of two uracil glycosylases, hUNG2 (human) and 
UDG (E. coli) on those DNAs under conditions that allow G4 to fold. Activities 
were compared to controls that cannot adopt G4 structures. We find that the 
excision of uracil is reduced when deoxyuracil is positioned directly adjacent to 
guanine repeats participating in G4 formation, but not when deoxyuracil is 
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located three bases away from the tetrad. Addition of APE1 to the reactions did 
not increase abasic site cleavage, suggesting that the initiating steps of BER of 
uracil are reduced at G4 DNA. Together, our results suggest that deaminated 
cytidines positioned adjacent to G4 DNA structures are poor substrates for the 
BER pathway. 
RESULTS 
G4 Formation with Deoxyuracil Oligonucleotides 
 We selected a G4 DNA sequence from the TCF3 (E2A) gene as a model 
structure, which we previously showed folds into G4 DNA at physiological salt 
and pH conditions in vitro (Williams et al., 2015) (Figure 20). The goal of this 
study was to simply test the efficiency of uracil excision activities on DNA 
containing deoxyuracil bases located directly next to (5’ or 3’) of a guanine tetrad. 
Therefore, oligonucleotides were synthesized to contain a single uracil lesion at 
defined positions and as such the U7, U15, and U24 sequences contain a 
deoxyuracil at position 7, 15 and 24, respectively (Figure 20A). The deoxyuracil 
is placed directly 5’ (U7), 3’ (U24) or in between (U15) the guanine repeats 
participating of G4 formation (Figure 20A). Control DNAs were sequence paired 
to the uracil-containing G4 oligonucleotide, except that the guanine repeats were 
interrupted with thymine to eliminate stable G4 folding (Figure 20A). These 
oligonucleotides are distinguished from one another by the terminology “G4” 
(with guanine repeats) or “GT” (thymine substituted). One important experimental 
consideration regarding G4 DNA is that a sequence capable of intra-molecular 
G4 formation will also permit inter-molecular G4 conformations in solution (Sen 
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and Gilbert, 1990, 1992). Therefore, we expected to observe a mixture of both 
conformations (Figure 20B). Independent of the precise G4 structure that forms, 
the U7 and U24 uracil bases will be adjacent to a tetrad. Structure prediction 
using the Mfold server (Zuker, 2003) did not return any significant fold-back 
structures for the GT oligonucleotides (ΔG < -1.0 kcal/mol). For the G4-capable 
sequences, the QGRS G4 prediction software (Kikin et al., 2006) verified that the 
most likely G4 conformation will involve the longest guanine repeats (using an 
input with a G-group of four and minimum loop of 1). That results in placement of 
the U7 and U24 deoxyuracils directly next to a tetrad in either intra-molecular or 
inter-molecular G4, and this is depicted in Figure 20B.  This remains the 
predominant structure predicted by the program even when the input parameters 
are reduced to a G-group size of three. Alternate G4 conformations are 
theoretically possible, but if they do form they would most likely exist as a 
collection of various minor G4 species in addition to the two predominant inter- 
and intra-molecular conformations predicted by QGRS mapper (Figure 20B).  
Deoxyuracil differs from deoxythymine by only a single methyl group, so 
we predicted that substituting thymine for uracil in the TCF3 oligonucleotide 
would not disrupt G4 formation. Further, the deoxyuracils used here reside within 
a loop, or between G-tetrads (Figure 20A and 20B), so we did not expect to see 
alterations in guanine-guanine pairing. In other G4 studies, telomeric G4 
structures were shown to maintain stability when thymine was substituted for 5-
hydroxymethyluracil, a major oxidation product (Konvalinová et al., 2015; Virgilio 
et al., 2015), so we infer that changes to bases not directly participating in G4 
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folding will not disrupt the structure. Guanine repeats are needed though, and 
interruption of those sequences by thymine substitution would eliminate the 
possibility of G4 formation. Consistent with that, QGRS mapper returned no 
scores for the GT oligonucleotides used here, indicating the absence of G4 
folding potential. In order to experimentally verify G4 formation for the 
deoxyuracil oligonucleotides used here we applied two different approaches, 
native PAGE and Circular Dichroism (CD). In native PAGE, G4 DNA structures 
migrate faster (intramolecular) or slower (intermolecular) compared to unfolded 
controls of similar molecular weight (GT). In the presence of 100 mM KCl, the 
migration patterns for G4(U7), G4(U15), and G4(U24) are entirely consistent with 
G4 DNA (Figure 21A). This matches previous results showing G4 formation with 
TCF3 sequences in KCl salt, except those oligonucleotides did not contain 
deoxyuracil (Williams et al., 2015).  The GT controls for each G4 sequence 
migrate predominately as a single species (Figure 21A), as expected. The 
G4(U24) oligonucleotide paired with complement (double stranded) migrates 
predominately as a single species and slower than the single-stranded 
counterparts, as expected (Figure 21A). 
CD measures the absorbance of circularly polarized light by chiral 
molecules and G4 DNA structures produce characteristic CD spectra, with 
ellipticity maximums at either 264 or 295 nm, and minima at either 265 or 240 nm 
(Balagurumoorthy et al., 1992; Dapić et al., 2003; Kypr et al., 2009; Vorlíčková et 
al., 2012). We applied CD analysis to the deoxyuracil containing GT and G4 
oligonucleotides shown in Figure 20A to measure their ability to fold into G4 DNA 
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in the presence of 100 mM KCl. Only the oligonucleotides containing guanine 
repeats (G4) produced spectra characteristic of G4 DNA (Figure 21B), consistent 
with earlier results (Williams et al., 2015). Interruption of the guanine repeats 
(GT) resulted in a CD spectral shift for each oligonucleotide (Figure 21B). We 
conclude that the TCF3 oligonucleotides containing deoxyuracil fold into G4 DNA 
structures, and the GT control sequences do not adopt G4 DNA.  
G-Tetrads Interfere with Bacterial UDG Activity  
We next asked if uracil glycosylase is active at deoxyuracils residing within 
guanine-rich DNA and next to a G4 tetrad. We first tested E. coli UDG. Each 5’ 
32P end-labeled and uracil-containing G4 and GT oligonucleotide was incubated 
with UDG, and after alkaline lysis of the abasic sites the cleavage products were 
resolved by denaturing PAGE. Generally, G4 is stabilized in solutions containing 
physiological concentrations of K+ and in neutral pH, and it is less stable in the 
absence of K+ salts or in the presence of Li+ (Sen and Gilbert, 1990; Sundquist 
and Klug, 1989; Williamson et al., 1989) Therefore, we performed UDG reactions 
in either 0 mM, 50 mM or 100 mM KCl, anticipating that 100 mM KCl will result in 
the most stable G4 DNA. One representative phosphorimage for each PAGE-
resolved cleavage assay is shown in figure 22 (left), and to the right of each 
image are graphs depicting the quantitation of cleavage from at least three 
independent experiments. In the absence of KCl, all six oligonucleotides were 
cleaved with near equal efficiency, regardless of the position of the deoxyuracil 
(Figure 22 A-C). In contrast, UDG activity on G4(U7) and G4(U24) was sharply 
reduced in the presence of KCl compared to each companion GT control (Figure 
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22A and 22C).  KCl had only a marginal effect on the cleavage activity of UDG 
on G4(U15) (Figure 22B). In contrast, the presence of KCl had a strong effect on 
the ability for UDG to cleave G4(U7) and G4(U24), with more than 5-fold fewer 
uracils removed compared to reactions that did not contain KCl (Figures 22A and 
22C).  KCl at concentrations up to 100 mM did not measurably effect UDG 
activity on any of the GT oligonucleotides, so the reduction in UDG activity 
observed for G4(U7) and G4(U24) was not due to the ionic strength of the 
reaction. Furthermore, UDG showed equivalent activity on all oligonucleotides 
tested when LiCl was substituted for KCl, up to 100 mM (Figure 20). Together, 
we concluded that uracil bases located next to guanine repeats are excised by 
UDG. However, UDG does not cleave the uracil as efficiently when those repeat 
participate in G4 formation compared single-stranded DNA of identical sequence.  
G-Tetrads Interfere with hUNG2 Activity 
Even though uracil DNA glycosylase is a highly conserved enzyme (Olsen 
et al., 1989), we next asked if the human UNG2 enzyme shows the same 
reluctance to process uracil near G4 DNA structures. We performed an identical 
set of cleavage assays, except that hUNG2 was substituted for E. coli UDG 
(Figure 23). The activities observed for hUNG2 on each oligonucleotide 
paralleled results obtained for E. coli UDG (Figure 22). Compared to the GT 
oligonucleotide, hUNG2 showed reduced activity on G4(U7) and G4(U24) 
oligonucleotides, but only when KCl and guanine repeats are present (Figures 
23A and 23C), whereas activity on G4(15) was indistinguishable from GT(U15) 
(Figure 23B). The reduced activity is most likely due to the formation of G4 
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structures because it was only observed when K+ ions are included in the 
reaction. Identical reactions performed in the presence of LiCl instead of KCl 
resulted in full hUNG2 activity (Figure 26). We conclude that hUNG2 activity is 
inhibited at uracils positioned adjacent to the G4-tetrads, at least for G4 DNA 
structures formed by the TCF3 oligonucleotide. Further, it appears that weak 
cleavage activity at G4 DNA is a likely a conserved property of the human 
(hUNG2) and E. coli UDG enzymes. 
In humans, abasic DNA is cleaved by the AP-endonuclease (APE1) 
enzyme and it was recently demonstrated that APE1 activity is inhibited at G4 
DNA (Broxson et al., 2014), suggesting that BER may be compromised at 
guanine-rich loci. We further tested the efficiency of uracil repair by co-incubating 
hUNG2 and APE1 with U7, U15 and U24 G4 and GT oligonucleotides all under 
G4 folding conditions. As expected, deoxyuracil was poorly cleaved from the 
G4(U7) and G4(U24) oligonucleotides by hUNG2 and APE1 compared to GT(U7) 
and GT(U24) (Figure 24A and C). The cleavage difference between G4 and GT 
was highly significant (two tailed t-test, P<0.002). The G4(U15) oligonucleotide 
was processed at essentially the same efficiency as GT(U15), although there 
was as modest, but not significant (P>0.20), reduction in abasic site cleavage for 
the G4(U15) oligonucleotide (Figure 24B).  This compares well to alkaline 
cleavage results (Figure 23), with the exception that APE1 displayed a lower 
overall ability to cleave (Figure 24). This suggests that not all abasic sites were 
cut by APE1 because treatment with NaOH resulted in ~90% of the GT 
oligonucleotides cleaved in every uracil glycosylase assay (Figure 22, 23, 25 and 
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26). Even so, the GT controls are used here as substrate comparisons for the G4 
structures, and we conclude that deoxyuracils located next to a G-tetrad are 
poorly excised by hUNG2 even when APE1 is included in the reaction.  
DISCUSSION  
G4 DNA structures that form in the genome promote genetic instability 
and human disease (Cea et al., 2015; Maizels, 2015), yet the reasons why are 
not fully defined. In this work we asked if G4 DNA structures, or more precisely 
the presence of G-tetrads, are an impediment to uracil repair in vitro. Both UDG 
and hUNG2 have been well characterized for their activity on uracils residing in 
either single or double stranded DNA substrates. We found that UDG and 
hUNG2 efficiently cleaved uracil from the unstructured single-stranded TCF3 
DNA and from the repeat disrupted (GT) oligonucleotides (Figures 22 and 23), 
showing equal activity for the repeat containing and control DNAs. This was in 
contrast to the lower activity observed on the G4 oligonucleotides U7 and U24 
under G4 folding conditions (Figure 22A, C and 23A, C). The addition of salt to 
the reactions did not reduce excision activity on the G4(U15) oligonucleotide 
(Figure 22B, 23B), arguing that it is the position of the deoxyuracil relative to G4 
and not the ionic strength of the reaction that affected cleavage efficiency. 
Furthermore, reactions that replaced KCl with a salt that does not support TCF3 
G4, LiCl (Williams et al., 2015), returned full cleavage activity on the G4(U7) and 
G4(U24) (Figure 25 and 26). We suggest that the G4 structure formation within 
G4(U7) and G4(U24) place the deoxyuracil in a molecular geometry that is less 
accessible to either UDG or hUNG2 activity. Indeed, moving the deoxyuracil 
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three nucleotides from a tetrad G4(U15) results in nearly full glycosylase activity 
compared to single-stranded conformations (Figure 22B and 23B). While these 
experiments do not resolve whether G-tetrads are an impediment to substrate 
recognition or cleavage by UDG and hUNG2, both enzymes do appear to share 
the property of having relatively weak activity next to G4 DNA structures.  
Our study is limited to the analysis of a single deoxyuracil placed at three 
different positions relative to guanine repeats in a synthetic oligonucleotide that 
can participate in G4 formation. Based on our results, it seems likely that a 
deoxyuracil located directly adjacent to a guanine tetrad will be poorly repaired 
by UNG-initiated BER. Since we have used a single sequence (albeit more than 
one structural conformation) we cannot exclude the possibility that uracil excision 
activity may be more efficient at G4s folded from other genomic sequences or 
other G4 conformations. It is possible that G-tetrads are a general impediment to 
uracil excision activity by UNG enzymes, but cytidine deaminations within 
sequence contexts that support alternate G4 conformations, such as anti-parallel 
or Na+ stabilized G4s, could feasibly be better substrates. Furthermore, 
considering the apparent abundance and complexity of unstable G4 loci in the 
human genome (Cea et al., 2015; Davis and Maizels, 2011; Maizels, 2015), it will 
be important to further characterize the limits of uracil excision activity on a wider 
range of G4 structural conformations.  
During transcription or replication, when DNA is transiently denatured, 
cytosine is exposed to hydrolytic deamination at a rate orders of magnitude 
higher than that of duplex DNA (Barnes and Lindahl, 2004). Presumably, 
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unpaired cytidines present within G4 DNA structures will also be prone to 
deamination, and our results suggest hUNG2 may not efficiently remove these 
particular base lesions. Even so, there are three other glycosylases that are 
capable of removing uracil from DNA with varying efficiencies (Krokan and 
Bjørås, 2013; Krokan et al., 2002; Krokan et al., 2014), and some or all could 
feasibly substitute for hUNG2 at G4 DNA. Using telomeric G4 substrates and 
glycosylases specific to oxidized DNA damage, it was shown that 8-oxyguanine 
was not processed, but other oxidation products were excised by the NEIL 
glycosylases (Zhou et al., 2013) suggesting that G4 DNA does not inhibit every 
glycosylase. Furthermore, some repair pathways appear to not be affected by G4 
DNA, O(6)-alkylguanine in telomeric G4 was shown to be repaired by 
alkylguanine alkyltransferase at levels comparable to duplex DNA (Hellman et 
al., 2014).  
One prediction from our results is that the occurrence of cytidines in the 
genome would be uncommon next to guanine repeats that are frequently 
participating in G4 formation, such as the telomeres (Sundquist and Klug, 1989; 
Williamson et al., 1989). This is because unrepaired cytidine deaminations due to 
reduced BER at those sites would cause C to T mutagenesis. There is some 
evidence to support that model. In vertebrates, telomere repeats do not contain 
any cytosines on the guanine-rich strand. Moreover, a compilation of known G-
rich telomere repeat sequences from animals, plants and fungi species shows 
that cytosines are rare and, if they are present in the repeat, they do not reside 
directly next to tandem guanines (Podlevsky et al., 2008) and would therefore not 
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be directly adjacent to a G4 tetrad. It is therefore interesting to speculate that the 
frequency of G4 formation in the cell may be a reflection of the sequence context 
and size of the looped regions, with the possibility that in the genome G4-capable 
sequences containing cytosine loops infrequently participate in stable or 
persistent G4 formation. Indeed, it was recently shown in yeast that both 
minisatellite instability and the thermal stability of G4 structures increases for 
sequence variants that contain shortened pyrimidine loops, which happen to be 
rare G4 sequences in the yeast genome (Piazza et al., 2015). If selection acts to 
favor genetic stability at a given G4 locus, our results provide a possible 
molecular mechanism for that evolutionary force and an explanation for the 
paucity of short pyrimidine loops between G-tetrads. Cytidine damage may be 
poorly repaired in the context of G4 DNA, and if damage occurs within stable G4 
structures, this could result in unresolved DNA repair intermediates, or 
mutagenesis, at those sites. 
In conclusion, we have used a model G4 forming sequence from the TCF3 
gene to ask if G4 DNA structures have the potential to interfere with uracil 
excision activities. Both bacterial UDG and hUNG2 shared a reluctance to cleave 
uracils next to G-tetrads, but showed full activity on control oligonucleotides that 
cannot adopt DNA structure, and full activity on guanine repeat oligonucleotides 
in conditions that do not support G4 formation. The addition of APE1 to the 
reaction did not improve excision activity, supporting the notion that the base 
excision repair pathway is not fully activated at uracil bases in G4 DNA. Guanine-
rich loci are known to be genetically unstable, and our results suggest that 
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defects in base excision repair of uracil at G4 DNA can contribute to 
mutagenesis.  
MATERIALS AND METHODS 
Substrate Preparation 
Deoxyuracil-containing G4 sequences were based on previously 
described G4 sequence from the TCF3 gene (Williams et al., 2015). All 
oligonucleotides were synthesized by Eurofins MWG Operon (Huntsville, AL) and 
PAGE purified.  Oligonucleotides were 5’ end labeled with γ-P32 ATP from MP 
Biomedicals (Solon, OH) and with T4 PNK, New England Biolabs (NEB) 
(Ipswich, MA). Unincorporated label was removed by spin chromatography using 
an Illustra Microspin G-50 column from GE Healthcare (Pittsburg, PA) using the 
manufacturer’s instructions.  
PAGE Analysis 
G4 and GT oligonucleotides were both subjected to the same G4 folding 
conditions. Reactions (10 µl) contained 5 pmols of labeled oligonucleotide and 
100 mM KCL in TE. The DNA was first denatured in a small > 98˚C water bath, 
and which was allowed to slowly cool to room temperature to permit structure 
folding. Samples were resolved by either native 16% PAGE (29:1) for 600Vhrs in 
0.5X TBE, or denaturing PAGE containing 7 M Urea 550 V for 20-35 minutes. 
Circular Dichroism 
CD detection of TCF3 G4 was performed as previously described 
(Williams et al., 2015). Briefly, we used an Aviv model 215 CD spectrometer at 
37°C and a 1 cm cuvette. Oligonucleotides were prepared at 12.5 µM in 10 mM 
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Tris-HCl (pH 7.6), 1 mM EDTA, and 100 mM KCl. Molar ellipticity was taken from 
200 nm to 300 nm in 1 nm increments. The averages of three different scans for 
each oligonucleotide analyzed were used.  
Uracil Glycosylase and APE1 Cleavage Assays 
Purified E. coli UDG and hAPE1 were purchased from NEB (Ipswich, MA) 
and hUNG2 from Enzymax (Lexington, KY). G4 DNA oligonucleotide structures 
were formed from 5 pmol of labeled DNA in 10 μl of 100 mM KCl and 1X UDG 
reaction buffer (20 mM Tris-HCl, 1 mM DTT, 1 mM EDTA, pH 8.0). Structures 
were folded in a ABI 2720 Thermal-cycler (Foster City, CA) set at the following 
temperatures held a 5 minute intervals; 98°C, 90°C, 75°C, 60°C, 45°C, 30°C, 
20°C. Samples were then immediately placed on ice. Cleavage assays contained 
indicated enzymes and incubated at 37°C for 20 minutes (glycosylase reactions) 
and 60 minutes for reactions containing both hUNG2 and APE1. Reactions were 
halted by addition of an equal volume addition of 1.8% SDS and 100 μg/ml 
Proteinase K Fermentas (Waltham, MA) solution.  The abasic sites of the UDG 
and hUNG2 reactions were cleaved with 333 mM NaOH and by heating at 55°C 
or 10 minutes. All enzymatic reactions were resolved using a 16% 
polyacrylamide (19:1) with 7 M urea and 0.5X TBE and with formamide load dye. 
100 mM KCl was included in both the gel and buffer to stabilize G4 structures. 
Gels were resolved at 550 V for 20-35 minutes, depending on the 
oligonucleotide. Images were collected using a Typhoon FLA 7000 
phosphorimager and bands quantified using ImageQuant TL software (GE 
Healthcare). Pixel density ratios were used to score enzyme activity and graphed 
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as the percentage of the total cleaved. Enzymatic reactions were repeated at 
least three times (n=3) for each oligonucleotide and displayed with standard 
deviation. One representative phosphorimage was selected for each figure. 
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FIGURES 
 
Figure 20. Sequences Used and Diagrams of G4 Structures. (A) The name (left) and 
sequence (right) for each oligonucleotide are shown. G4 and GT indicate 
oligonucleotides capable or incapable of adopting G4, respectively. The nucleotide 
position of the deoxyuracil base, U7, U15, and U24 relative to the 5’ end is indicated 
within each oligonucleotide name. The positions of deoxyuracil bases within each 
sequence are underlined and guanine repeats are bolded. Substitution of thymine for 
guanine interrupts G4 folding potential, shown with an italicized “T”. (B) Diagram 
depicting intramolecular, left, or intermolecular, right, G4 conformations and the relative 
positions of each deoxyuracil (asterisks). All three uracils positions are depicted on a 
single G4 conformation for convenience.  Diagrams are not scaled models. Actual G4 
conformations in solution are predicted to be a mixture of intra and inter-molecular 
species, but U7 and U15 will be adjacent to a tetrad. 
  
A. 
 
 
 
 
B. 
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Figure 21. Detection of G4 Formation. (A) Phosphorimages showing native PAGE 
resolution of 5’ 
32
P end labeled G4 and GT oligonucleotides in neutral pH and 100 mM 
KCl. The name of each oligonucleotide is shown at the top. Oligonucleotides where 
guanine repeats are interrupted by thymine to prohibit G4 formation (GT) migrate 
predominately as a single species. Guanine repeat oligonucleotides (G4) migrate faster 
(arrow) and slower (bracket) than each control (GT). All oligonucleotides are equal 
nucleotide length and migration of G4(U24) duplex DNA (DS) is shown as a reference 
for double-stranded DNA. (B) CD of each G4 and GT deoxyuracil-containing 
oligonucleotide. Ellipticity is shown on the Y axis, wavelength (nm) on the X axis. 
Spectra for uracil containing oligonucleotides with guanine repeats (G4) are in black, 
repeat interrupted (GT) oligonucleotides in grey. All oligonucleotides were assayed in 
100 mM KCl solution at pH 7.6. 
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Figure 22. G-Tetrads in TCF3 G4 Interfere with UDG Activity. (Left) Representative 
phosphorimages of E. coli UDG cleavage assays for each 5’ radiolabeled 
oligonucleotide are shown. Reactions were performed at the indicated salt conditions (0, 
50 and 100 mM KCl), followed by alkaline lysis and resolution of the cleavage products 
by denaturing PAGE. Oligonucleotides contained a single deoxyuracil at position 7 (A), 
15 (B), or 24 (C) in sequences capable of forming G4 (G4) or controls where the guanine 
repeats were interrupted with thymine to prohibit G4 formation (GT). The presence (+) or 
absence (-) of UDG is indicated at the top. An arrow shows the position of the cleavage 
products. (Right, A-C) Quantitation of the percentage cleaved by UDG (Y axis) for each 
oligonucleotide at the indicated salt concentration (X axis). Values are means from three 
independent experiments, with standard deviation.  
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Figure 23. G-Tetrads in TCF3 G4 Interfere with hUNG2 Activity. (Left) 
Representative phosphorimages of hUNG2 cleavage assays for each 5’ radiolabeled 
oligonucleotide are shown. Reactions were performed at the indicated salt conditions (0, 
50 and 100 mM KCl), followed by alkaline lysis and resolution of the cleavage products 
by denaturing PAGE. Oligonucleotides contained a single deoxyuracil at position 7 (A), 
15 (B), or 24 (C) in sequences capable of forming G4 (G4) or controls where the guanine 
repeats were interrupted with thymine to prohibit G4 formation (GT). The presence (+) or 
absence (-) of hUNG2 is indicated at the top. An arrow shows the position of the 
cleavage products. (Right, A-C) Quantitation of the percentage cleaved by hUNG2 (Y 
axis) for each oligonucleotide at the indicated salt concentration (X axis). Values are 
means from three independent experiments, with standard deviation.  
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Figure 24. G-Tetrads in TCF3 G4 Interfere with the Cleavage Step of Base Excision 
Repair. (Left) Representative phosphorimages showing the activity of both hUNG2 and 
APE1 on single deoxyuracil bases placed at positions 7 (A), 15 (B), or 24 (C) in G4 DNA 
folded from the TCF3 oligonucleotide (G4) or control oligonucleotides that cannot fold 
into G4 structures (GT). Reactions contained 100 mM KCl and the presence (+) or 
absence (-) of hUNG2 or APE1. Cleavage products (arrow) were resolved by denaturing 
PAGE. (Right) Quantitation of a least three independent experiments are displayed on 
the right of each representative phosphorimage. The percentage cleaved by APE1 
activity (Y axis) is shown for each G4 (X axis left) or GT (X axis right), with standard 
deviation and P values (two-tailed t test).  
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Figure 25. LiCl Does Not Inhibit UDG Activity (Left) Phosphorimages of UDG activity 
assays resolved by denaturing PAGE. Assays were identical to those presented in 
Figure 3, except that LiCl was substituted for KCl. (Right) Quantitation of UDG cleavage 
in the presence of LiCl at the indicated concentrations. Pixel means were derived from at 
least three independent experiments, with standard deviation. 
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Figure 26. LiCl Does Not Inhibit hUNG2 Activity (Left) Phosphorimages of hUNG2 
activity assays resolved by denaturing PAGE. Assays were identical to those presented 
in Figure 4, except that LiCl was substituted for KCl. (Right) Quantitation of hUNG2 
cleavage in the presence of LiCl at the indicated concentrations. Pixel means were 
derived from at least three independent experiments, with standard deviation. 
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CHAPTER V 
FURTHER CHARECTERIZATION OF URACIL GLYCOSYLASE ACTIVITY ON G4 DNA 
SUBSTRATES 
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INTRODUCTION 
As demonstrated in chapter II, the monoubiquitination of histones is one of 
many potential key molecular beacons that may recruit the DNA modifying 
enzyme activation induced cytosine deaminase (AID). However, the full 
complement of molecular interactions responsible for AID targeting to the 
immunoglobulin (Ig) locus remains a critical question that must be resolved. The 
specificity and efficiency of AID targeting to the Ig locus is most likely regulated at 
multiple levels using independent cellular mechanisms and it will probably require 
collaborative efforts to determine how all these regulatory elements interact and 
direct the targeting of AID (Delker et al., 2009; Stavnezer, 2011). The Ig locus 
contains a “perfect storm” of molecular and sequence conditions that ensure 
targeted genomic rearrangements to produce novel antibodies. Although many 
other loci share some of the same molecular beacons, AID induced lesions at 
non Ig loci remain below the mutagenic threshold and DNA repair is able to 
overcome the mutagenic threat and maintain genomic integrity. 
Recently, CHIP-seq analysis of B cells demonstrated that AID targets over 
5,000 transcribed genes and some of these non-Ig loci have increased levels of 
mutagenesis (Yamane et al., 2011). This clearly highlights the potency of AID to 
act as a global genomic mutator and argues for the existence of powerful 
regulators to tightly control AID expression and deamination activity. Chapter III 
of this manuscript characterizes the 3’ untranslated region of AID mRNA and 
shows that miR-93 and miR-155 are able to post transcriptionally regulate the 
levels of functional AID within RAMOS B cells. The model suggests, miR-93 and 
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miR155 act as genomic sentries that protect DNA from the mutational processes 
of AID.  
One characteristic that is shared between the Ig locus and off target genes 
deaminated by AID is that they are highly transcribed (Chaudhuri et al., 2003), 
which also provides the conditions necessary to form G4 DNA structures at these 
loci. AID preferentially deaminates single strand DNA and is capable of acting on 
both the template and non-transcribed strands (Bransteitter et al., 2003; 
Dickerson et al., 2003; Pham et al., 2003; Ramiro et al., 2003; Shen and Storb, 
2004; Sohail et al., 2003). As stated above, off target mutations created by AID 
are corrected by DNA repair mechanisms. Identifying how these pathways can 
be overwhelmed is a critical component in understanding genomic instability and 
genetic disease. In Chapter IV evidence is provided showing the base excision 
repair (BER) pathway is poorly initiated by uracil DNA glycosylase (UDG) 
enzymes when the lesion is directly adjacent to guanine repeats that are involved 
in G4 DNA structure formation. These experiments were designed simply to 
determine if G4 DNA affects UDG activity on a pool of substrates containing both 
intra- and inter-molecular G4 DNA conformations. The rest of this manuscript 
outlines experiments that are underway to further elucidate how G4 DNA 
structures alter the efficiency of BER. 
In order to further characterize UDG activity on G4 DNA another 
oligonucleotide substrate was designed. The sequence allows for the 
investigation of glycosylase activity on only two species of multi-molecular G4 
DNA substrates (G4 and G2’) (Figure 27B and C), which have been well 
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characterized (Sen and Gilbert, 1992). The advantages to using this substrate 
design are twofold. First, it controls for the number of potential G4 structures due 
to the fact that only multi-molecular G4 motifs can fold. Second, the structures 
are stable in lower concentrations of KCl (10 mM), which allows for the 
investigation of UDG as well as single-strand selective monofunctional uracil 
DNA glycosylase (SMUG1) an enzyme that is salt sensitive. The following 
experiments will demonstrate that UDG inhibition extends to SMUG1 when the 
uracil is located within guanine repeats under G4 stabilizing conditions. 
RESULTS 
Uracil Does Not Disrupt Inter-Molecular G4 DNA Formation 
Native PAGE was performed comparing DNA migration of samples under G4 
folding conditions to those that promote a single stranded conformation (Figure 
27A). When multi-molecular G4 DNA is present it involves the interaction of two 
or four oligonucleotides, making it a much larger structure forcing it to migrate 
more slowly through the gel relative to single-strand DNA (Figure 27A). For each 
sequence analyzed there was a noticeable shift up when the DNA was subjected 
to G4 folding conditions (100 mM KCl) (Figure 27A). The folded samples show a 
mix of multi-molecular G4 DNA structures with G2’ migrating faster than G4 DNA 
but still much slower than single strand substrates (Figure 27A). The 
oligonucleotide containing the scrambled (520scr) sequence disrupting the 
guanine repeats shows no such mobility shift during native PAGE when KCl is 
present (Figure 27A). The highly repetitive nature of the DNA oligonucleotide 
sequence allows for hairpin formation and accounts for the doublet that is seen 
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when the samples are under single strand conditions (Figure 27A). The DNA 
sequences are outlined in Table V-1 and show a single uracil substitution within 
each oligonucleotide. The structures depicted in Figure 27A and 27B have an 
asterisk at the nucleotide position representing the location of the single uracil 
substitution. 
UDG is Inhibited When the Lesion is Located Within G4 DNA Structures 
The uracil glycosylase activity assays were carried out in non-denaturing reaction 
conditions before being subjected to DNA alkaline lyses and denaturing PAGE.  
The oligonucleotides were used to assay the ability of UDG to process uracil in 
conditions that promote G4 structure formation. The ratio of substrate to product 
created by UDG is used to quantify the ability of UDG to act of G4 DNA. When 
the guanine repeats are disrupted and the oligo is unable to form a G quadruplex 
structures there is no difference in UDG processing between linear and G4 DNA 
conditions (Figure 28A, 520scr). However when the sequence and reaction 
conditions allow for G4 to form, a significant reduction in uracil processing is 
evident by the presence of an increased amount of intact substrate (Figure 28A, 
EDL520, EDL521, EDL523, EDL524). Interestingly, when the uracil lesion is 
found outside of guanine repeats that participate in G4 folding there is no 
difference in UDG processing between linear and G4 folding conditions (Figure 
28A, EDL522). The trend of UDG inhibition in a G4 DNA context can clearly be 
seen when average uracil processing of several gels (n=3) is graphed (Figure 
28). Under linear conditions there is no change in UDG processing between the 
different oligonucleotides examined. When the reaction conditions promote G4 
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DNA there is a significant reduction in uracil processing of between 
approximately 35% and 55% when the lesion is located within guanine repeats 
that participate in the G4 DNA structure formation. 
SMUG1 is Inhibited When the Lesion is Located Within G4 DNA Structures 
The same uracil glycosylase activity assay was repeated using hSMUG1 instead 
of UDG and similar results were observed. The scrambled sequence and the 
oligonucleotidess with the uracil lesions located outside of the guanine repeats 
involved in the G4 structure again showed no difference in SMUG1 processing 
between the linear (SS) and G4 folded DNA structures (Figure 29A, 520scr, 522). 
EDL522 reaches a maximum processing of just over 50% when it is linear or 
under G4 folding conditions. This may be due to SMUG1 having different 
specificity for single-strand and duplex DNA and the presence of hairpins in the 
oligo sequence. Again, the DNA sequences with a uracil within guanine repeats 
displayed SMUG1 processing inhibition within G4 structures compared to that of 
the single strand DNA samples (Figure 28A., 520, 521, 523, 524). A graph of 
SMUG1 processing was constructed using the average pixel density ratio of 
multiple gels (n=3) and the averages display the inability of SMUG1 to process 
uracil when found within guanine repeats participating in G4 structure formation 
DISCUSSION 
Chapter IV demonstrated that both E. coli UDG and human UNG2 have a 
reduced processing ability near G4 DNA that is capable of forming both 
intramolecular and intermolecular motifs. The sequence used here in Chapter V 
represents a generic G4 locus and was chosen because it forms distinct, well 
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characterized, intermolecular G4 DNA structures (Figure 27A) (Sen and Gilbert, 
1992). Experimentation on these oligonucleotides is crucial in characterizing the 
limits of uracil glycosylase sensitivity on intermolecular G4 substrates. When the 
oligonucleotides are subjected to UNG and SMUG1 processing it is clear that 
fewer uracil containing lesions are being processed when the DNA 
oligonucleotide is under G4 stabilizing conditions and the uracil is within guanine 
repeats (Figure 29 and Figure 29). Experiments using these oligonucleotides are 
still currently being performed in order to attain publication quality gels and 
replicates for statistical analysis. The glycosylase sensitivity demonstrated in 
Figures 28 and V-3 follows with recent data (not shown), in which inhibition of the 
glycosylase is only present when the lesion is found within the G4 DNA structure 
between two sets of tetrads (EDL520, 521,523,524) but the other uracil positions 
are accessible by the enzyme. This again shows that G4 DNA is an impediment 
to the efficient initiation of the BER pathway and provides a molecular 
mechanism that explains the association with G4 DNA and instability.  
CONCLUSION 
The work compiled in this manuscript elucidate several molecular 
mechanisms that are involved in maintaining genomic stability and provide 
significant contributions to the gaps in our current understanding of both targeted 
and spontaneous mutagenesis. The effect of structures on genomic stability is a 
recently discovered phenomenon and will remain relevant for some time due to 
the unique characteristics of individual DNA structures which provide a 
substantial substrate pool to be examined. 
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MATERIALS AND METHODS 
Substrates 
As a control to ensure that the G4 folding capability is sequence specific, a 
scrambled sequence was generated disrupting the guanine repeats and was 
unable to fold into G4 DNA (520scr). The deoxyuracil was placed at positions 
within guanine repeats participating in G4 structure folding and outside of the 
guanine repeats. All deoxyoligonucleotides were purchased from Eurofins MWG 
Operon (Huntsville, AL) and the uracil containing strands were PAGE purified.  
 The G4 folding conditions were, 500µM of DNA was incubated with TE 
(pH 7.9) in a 5µl volume at 98oC for 2 min and placed immediately on ice. A 1:1 
addition of salt mix (1.9M NaCl, 0.1M KCl) was added and incubated at 60oC for 
90 min followed by 7 hours at 37oC. Reactions were performed in thin walled 
PCR tubes (Fischer). DNA was stored at -20oC and appropriate dilutions were 
32P radio labeled and visualized by PAGE. The 32P radio label was ordered from 
MP Biomedicals (Santa Ana, Ca) and 5’ DNA end labeling was performed using 
NEB Polynucleotide Kinase following the supplier protocol to a final concentration 
of 5 µM. Unincorporated radio label was removed by spinning the sample 
through a G-50 micro columns (GE Healthcare) either equilibrated in TE or in TE 
with 10mM KCl (G4). 
Enzymes 
The purified enzymes were purchased commercially from NEB (UDG), enzymax 
(hUNG2) and Fermentas (SMUG1)  
 
 121 
Polyacrylamide Gel Electrophoresis 
To visualize the multi-molecular parallel DNA structures Native PAGE gels were 
prepared at 6% acrylamide (29:1) and run in 0.5x TBE with 50mM KCl. The 
samples were loaded in 50% glycerol with 10mM EDTA and bromophenol blue 
and run at 100 volts for 2 hours. The gel was exposed to the PhosphorImager 
screen and read using the Storm840 scanner (GE Healthcare). 
The enzymes and appropriate DNA substrates were incubated at 37°C for 
20 minutes under native conditions in buffers outlined by the enzyme 
manufacturer. Next, alkaline lyses of the abasic sites was performed by bringing 
the sample to 300 mM NaOH and incubated at 55°C for 10 minutes. An equal 
volume of 95% formamide with bromophenol blue was added to each sample 
and heated to 96°C for two minutes. The DNA was then loaded onto 15% 
denaturing urea gels and run at either 300 V or 700 V to resolve DNA fragments. 
Quantification of the image and a pixel density ratios of substrate to product 
formation were used to score the activity of each glycosylase on single-strand 
DNA and G4 DNA.  
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FIGURES 
 
Figure 27. Native DNA Structures. A) Native PAGE with oligonucleotides under single 
stranded (SS) and G4 conditions. Oligonucleotide structural conformation listed above, 
construct name listed below and DNA structure motif indicated on the right of the gel. B) 
G4 DNA oligo sequence and parallel G4 structure with asterisks representing nucleotide 
positions with a single uracil substitutions. C) Alternative G4 DNA structure (G2’) 
consisting of two oligonucleotides in an anti-parallel conformation with asterisks 
indicating a single uracil substitutions. 
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Figure 28. Bacterial Uracil DNA Glycosylase Activity on Single-Strand and G4 
Folded Substrates. A) Representative denaturing PAGE of individual oligonucleotides 
consisting of linear (SS) DNA and G4 folded (G4) structures incubated with or without 
uracil DNA glycosylase. B) Average UNG processing (n=3) for each individual 
oligonucleotide under single strand (black) and G4 conditions (white). 
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Figure 29. SMUG1 Activity on Single-Strand and G4 Folded Substrates. A) 
Representative denaturing PAGE of individual oligonucleotides consisting of linear (SS) 
and G4 folded (G4) structures incubated with or without SMUG1. B) Average SMUG1 
processing (n=3) for each individual oligo under linear (black) and G4 conditions (white). 
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TABLE 
 
Table 3. DNA Oligonucleotide Sequence. The left column indicates the oligo 
name. The right column is the uracil containing DNA oligo sequence with uracil 
underlined and written 5’ to 3’. 
 
 Name Sequence 
EDLSCR520 ATAGAGGCGACGGCGGTGAGAATAGAGTGUCGGCGAGTGATAGTCGCGG 
EDL520 TGGACCAGACCTAGCAGCTATGGGGGAGCUGGGGAAGGTGGGAATGTGA 
EDL521 TGGACCAGACCTAGCAGCTATGGGGGAGUTGGGGAAGGTGGGAATGTGA 
EDL522 TGGACCAGACCTAGCAGCUATGGGGGAGCTGGGGAAGGTGGGAATGTGA 
EDL523 TGGACCAGACCTAGCAGCTATGGGGGAUCTGGGGAAGGTGGGAATGTGA 
EDL524 TGGACCAGACCTAGCAGCTATGGGGGUGCTGGGGAAGGTGGGAATGTGA 
EDL522X TGGACCAGACCTAGCAGCTUTGGGGGAGCTGGGGAAGGTGGGAATGTGA 
EDL522XX TGGACCAGACCTAGCAGCTAUGGGGGAGCTGGGGAAGGTGGGAATGTGA 
EDL525X TGGACCAGACCTAGCAGCTATGGGGGAGCTGGGGAAGGTGGGUATGTGA 
EDL525XX TGGACCAGACCTAGCAGCTATGGGGGAGCTGGGGAAGGTGGGAUTGTGA 
EDL525XXX TGGACCAGACCTAGCAGCTATGGGGGAGCTGGGGAAGGTGGGAAUGTGA 
 
